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ABSTRACT 
 
Only a few years after the introduction of the first antibiotic, penicillin, in 1940, an 
antibiotic resistant strain of Staphylococcus aureus was identified. Over time bacteria 
have developed various mechanisms to inactivate antibiotics. Such antibiotic resistance 
in bacteria is a natural and inevitable process and represents a global threat. At the 
present time resistance to every main class of antibiotic has been observed. Therefore, 
the continuous development of new-generation antibiotics is crucial to combat the rise 
of antibiotic resistant strains. Identification of potential antibiotic targets and 
investigation of their structure and function represent a rational approach to developing 
a better understanding of the essential processes in which they are involved, and may 
lead to finding a mechanism to inhibit these processes.  
The first part of this thesis covers structural characterization and functional 
studies of the potential antibiotic targets TonB protein and the cell shape determining 
protein MreC. TonB is needed for TonB-dependent uptake of scarce nutrients, such as 
iron and vitaminB12. The cell shape determining protein MreC is involved in cell wall 
synthesis, which is the target of penicillin and its derivatives.  
In this study, the three dimensional structures of the C-terminal domain of 
Helicobacter pylori TonB of different lengths and the C-terminal domain of Bacillus 
subtilis MreC were determined using nuclear magnetic resonance (NMR) 
spectroscopy. Additionally, interaction studies of MreC with penicillin-binding 
proteins were done using NMR spectroscopy and a bacterial two-hybrid system.  
 NMR spectroscopy is a versatile tool to investigate protein structure, dynamics 
and interactions. One of the advantages of NMR is that proteins can be studied in 
solution under nearly physiological conditions. However, with increasing molecular 
size (> 25 – 30 kDa), structural investigation by NMR becomes more complex and 
often requires specific labelling techniques and alternative methodologies for NMR 
measurements, such as transverse-relaxation optimized spectroscopy (TROSY). 
Segmental isotopic labelling, where only a part of the protein is stable isotopic 
labelled, is an attractive method to overcome the challenges of studying large proteins 
by NMR. Segmental isotopic labelling allows, e.g. investigation of individual protein 
domains in a full-length context. For ligation of the protein domains different methods 
can be used.  
???
 Furthermore, NMR is a powerful tool to study the integrity of a protein. Certain 
requirements, however, have to be fulfilled: the protein has to be soluble at high 
concentrations and stable over the whole measurement time. Therefore it is important 
to optimize protein production in order to obtain soluble, properly folded proteins at 
high concentrations.  
 In the second part of this study, TonB has been used as a model protein to show 
traceless intein-mediated segmental isotopic labelling by salt induced protein trans 
splicing using a halophilic intein. This approach facilitates structural investigations of 
TonB by NMR. TonB consists of a well-structured C-terminal domain and a flexible 
proline-rich region, which would severely interfere with spectral quality in a uniformly 
labelled sample. Furthermore TonB was used as a model protein to show the benefit in 
protein expression of using tandem SUMO fusion vectors as tools for the expression of 
more soluble proteins, which tend to be expressed in an insoluble form. Both of these 
applications are beneficial for structural investigation of proteins by NMR and can be 
applied to other proteins.  
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1 GENERAL INTRODUCTION 
 
The original publications and manuscripts included in this thesis deal with structural 
and functional studies of two bacterial proteins, TonB from Helicobacter pylori and 
MreC from Bacillus subtilis. The structural studies are based on NMR spectroscopy. 
Additionally, the original publications describe the use of TonB protein as a model 
protein for biotechnological applications, such as segmental isotopic labelling and 
protein expression using fusion proteins for improved solubility.  
The first part of the introduction includes a literature overview and describes some 
aspects of the global problem of antibiotic resistance, including some mechanistic 
insights. The second part of the introduction describes the two proteins TonB and 
MreC as potential targets for new-generation antibiotics, including their specific roles 
in essential cellular processes.  
The next section gives an overview of protein structure determination by NMR and 
furthermore focuses on segmental isotopic labelling for NMR studies by protein trans 
splicing using inteins from extremely halophilic archaea. A short introduction about 
inteins in general is also included. The importance of soluble protein expression for 
NMR structural studies, and the use of SUMO fusion proteins for more soluble protein 
expression, is described in the same section. 
The results section of this thesis summarizes the results of the original research papers 
and manuscripts and also presents some unpublished results associated to the subject. 
The original research papers and the manuscripts contain results obtained using 
different experimental techniques from the field of molecular biology, protein 
chemistry, biotechnology and structural biology by NMR.  
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2 ANTIBIOTIC RESISTANCE IN BACTERIA 
 
The first reports of penicillin resistant Staphylococcus aureus were published in 1944, 
only 4 years after penicillin was introduced in the early 1940s (Neu 1992; Chambers 
2001). Nowadays, nearly all strains of S. aureus are resistant to all natural penicillins 
(Rice 2006; Neu 1992; Chambers 2001). The resistance was developed due to the 
acquisition of a gene that encodes β-lactamase, which is a penicillin-inactivating 
enzyme. Penicillin resistant S. aureus strains were first observed in hospitalized 
patients, however, over time the resistant strains also spread rapidly outside the 
hospital environment (Taubes 2008; Rice 2006). The development of the β-lactamase-
resistant penicillin derivative, methicillin, in 1959, was useful at first against penicillin 
resistant S. aureus strains. However, the first methicillin-resistant S. aureus (MRSA) 
strains appeared in 1961, only a few years after the introduction of methicillin 
(Chambers and Deleo 2009; Chambers 1988; Barber 1961; Jevons et al. 1961). As a 
consequence, methicillin is no longer used as an antibiotic. Over the years, different 
mechanisms for antibiotic resistance have developed in bacteria (Blair, Webber et al. 
2015). The genes encoding for antibiotic resistance are acquired either by vertical gene 
transfer which includes spontaneous mutations of the bacterial genome or more often, 
by horizontal gene transfer of mobile DNA segments, such as plasmids or transposons, 
from other bacteria in the environment (Alekshun and Levy 2007; Gyles and Boerlin 
2014; Koonin, Makarova et al. 2001). Acquisition of antibiotic resistance in bacteria is 
a natural process that cannot be prevented. According to the World Health 
Organization’s (WHO) report on antimicrobial resistance from 2014 (WHO, 2014), 
Escherichia coli, Klebsiella pneumonia, S. aureus and Streptococcus pneumoniae are 
resistant to more than 50% of the commercially available antimicrobial drugs in most 
WHO regions, including Europe. These are the key bacteria, responsible for common 
infections in hospitals as well as in the community in the whole WHO region (World 
Health Organization. Antimicrobial Resistance: Global Report on Surveillance (WHO, 
2014)). Many hospital-acquired infections caused by multidrug resistant bacteria 
cannot be treated with standard antibiotics and the mortality associated with these 
infections is about 20% (Rice 2006). About 25000 people in Europe die every year as a 
direct result of infections caused by multidrug-resistant strains (Walker et al, 2011). 
These bacteria that are difficult or even impossible to treat are a severe threat for 
?? ??
global public health. Therefore, development of novel antimicrobial drugs is crucial for 
treatment of these infections.  
However, development of new-generation antibiotics, either from natural products or 
synthetic antibiotics, has been challenging. From 1987 until 2011 no novel 
antimicrobial class has been introduced, and although continuous research for drug 
screening and design has been done, most of the compounds did not enter the clinic 
(Walsh 2003; Silver 2011). Interestingly, development of derivatives of already 
existing antibiotic classes by chemical modifications, is done continuously (Silver 
2011). These derivatives often have improved efficacy and the drug absorption is 
usually better, meaning that smaller amounts are needed compared to the parent 
compound (Walsh 2003). However, compared to the original compound, the 
chemically modified derivatives are similar in molecular structure and resistance to 
these derivatives can emerge rapidly (Walsh 2003).  
Since antibiotic resistance in bacteria cannot be avoided, the continuous development 
of novel classes of antibiotics to combat the rise of antibiotic resistant strains is crucial 
for global public health. 
 
2.1 Mechanism of antibiotic resistance 
 
Not all antibiotics are effective against the same bacteria. Bacteria can be intrinsically 
resistant to a certain class of antibiotics. Compared to Gram-positive bacteria, Gram-
negative bacteria are in general less sensitive to antibiotics, since the outer membrane 
of Gram-negative bacteria is a natural permeability barrier, which cannot be crossed by 
all antibiotics (Vargiu and Nikaido 2012; Kojima and Nikaido 2013; Vaara 1992; 
Poole 2001). The down-regulation of outer membrane non-selective porin has 
contributed to the intrinsic resistance to antibiotics of Gram-negative bacteria (Tamber 
and Hancock 2003). Furthermore, differences between Gram-positive and Gram-
negative bacteria in the phospholipid composition of the cytoplasmic membrane can 
influence the accessibility of certain antibiotics to their target (Tsuchido and Takano 
1988).  
Bacteria have acquired various mechanisms of antibiotic resistance either by vertical or 
horizontal gene transfer (HGT). The effectiveness of the antibiotic is decreased by one 
or more of the following three mechanisms: (i) reduction of the antibiotic 
?? ?
concentration to a minimum by efflux pumps or by changing the permeability of the 
membrane, (ii) modification of the antibiotic target, either genetically or by post-
translational modifications and (iii) inactivation of the antibiotic by chemical 
modification or hydrolysis (Fernandez and Hancock 2012; Blair, Webber et al. 2015; 
Wright 2011).  
 
(i) Efflux pumps are naturally present in Gram-negative as well as in Gram-positive 
bacteria, such as S. aureus or Klebsiella pneumoniae (Floyd, Smith et al. 2010). The 
pumps actively transport antibiotics out of the cell, thereby hindering the accumulation 
of antibiotics inside the cell, and their substrate specificity varies from very narrow to a 
wide range of structurally different substrates, the so called multi-drug (MDR) efflux 
pumps (Ogawa, Onishi et al. 2012). Genes encoding efflux pumps are often acquired 
by HGT in the form of a plasmid (Dolejska, Villa et al. 2013; McMurry, Petrucci et al. 
1980). The first cases of bacteria overexpressing efflux pumps were found in the 1990s 
and included E. coli, S. aureus and P. aeruginosa (Pumbwe and Piddock 2000; 
Kosmidis, Schindler et al. 2012; Everett, Jin et al. 1996).  
 
In the case of acquired antibiotic resistance by modification of the antibiotic target (ii), 
the target is modified, either genetically by mutation, or post-translationally, e.g. by the 
addition of a chemical group to the target binding site of the antibiotic. The 
modification does not influence the target’s activity significantly, nor does it change 
the substrate binding site. The aminoglycoside antibiotics, which include kanamycin 
and streptomycin, inhibit protein synthesis in Gram-negative bacteria by binding to the 
bacterial ribosome (Mingeot-Leclercq, Glupczynski et al. 1999). Methylation of the 
target ribosome leads to sterical hindrance and prevents binding of the antibiotics 
(Long, Poehlsgaard et al. 2006; Giessing, Jensen et al. 2009). Genes encoding for 
enzymes responsible for the methylation of the ribosome can be acquired by HGT and 
their enzymes have been detected in antibiotic resistant strains of Enterobacteriaceae in 
Europe as well as in North and South America (Zhang, Xu et al. 2014; Fritsche, 
Castanheira et al. 2008). 
 
In the case of direct modification of the antibiotic (iii), two mechanisms are possible, 
either degradation of the antibiotic by hydrolysis or the addition of a chemical group to 
the antibiotic. The addition of a chemical group leads to inhibition of the interaction 
?? ??
with the target. One of the most common enzymes that provides antibiotic resistance in 
bacteria is β-lactamase. β-lactamase hydrolyses the functionally important β-lactam 
ring of penicillin and its derivatives, thereby inactivating the antibiotics (Livermore 
2008; Voulgari, Poulou et al. 2013; Woodford, Turton et al. 2011). The plasmid 
containing the gene for β-lactamase is wide spread, in particular among 
Enterobacteriaceae (Dhanji, Khan et al. 2012; Cottell, Webber et al. 2011). 
Interestingly, the first cases of β-lactamase were reported already before penicillin was 
clinically used in 1940 (Abraham and Chain 1988). Nowadays, bacterial strains, e.g. of 
E. coli and K. pneumoniae can be isolated that are resistant to all β-lactam antibiotics 
(Lynch, Clark et al. 2013; Johnson and Woodford 2013). The modification of 
antibiotics by transfer of a chemical group, such as an acyl or phosphate group by 
acetyltransferases or phosphotransferases, has been widely observed, particularly with 
aminoglycoside antibiotics. Aminoglycosides have many exposed hydroxyl and amide 
groups and this type of resistance has been associated with infections from antibiotic 
resistant Campylobacter strains (Toth, Frase et al. 2013; Qin, Wang et al. 2012).  
 
The current overuse and misuse of antibiotics in medicine and agriculture put bacteria 
under extreme evolutionary pressure and support the rapid spread of new antibiotic 
resistant strains. Awareness of the threat of antibiotic resistant strains has to be raised 
and information about appropriate use of antibiotics in medicine as well as in 
agriculture needs to be spread globally. 
 
2.2 Targets of antibiotics 
 
Antibiotics interfere with different cellular processes, which are briefly listed here. The 
interaction of the antibiotic with the drug target leads to a breakdown of the cellular 
process and to subsequent cell death. Antibiotic targets generally are key proteins of 
the following cell processes: Cell wall synthesis, DNA replication, RNA synthesis and 
protein synthesis (Walsh, 2003)a.  
 
Antibiotics interfering with proteins of cell wall synthesis belong to the class of β-
lactam antibiotics and glycopeptides, such as penicillin or cephalosporin and 
vancomycin, respectively. β-lactam antibiotics are used for treatment of infections 
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caused by Gram-negative as well as by Gram-positive bacteria, whereas glycopeptides 
are efficient only against Gram-positive bacteria. β-lactam antibiotics bind to penicillin 
binding proteins (PBPs), which belong to the class of acyl serine transferases and are 
responsible for the final step in peptidoglycan synthesis, namely the cross-linkage 
between peptides of peptidoglycan (Scheffers and Pinho 2005; Lim and Strynadka 
2002; Holtje 1998; Wise and Park 1965). Binding of antibiotics to PBPs inhibits the 
peptide-bond formation between peptidoglycan layers, and as a consequence of this 
antibiotic-PBP interaction, cell lysis is triggered (Kohanski, Dwyer et al. 2010). 
Antibiotics interfering with DNA replication belong to the class of quinolones and its 
derivatives, e.g. fluoroquinolones such as ciprofloxacin or levofloxacin. They enter the 
bacterial cell via outer membrane proteins like porins and are used against Gram-
negative and Gram-positive bacteria (Andersson and MacGowan 2003; Neves, 
Berkane et al. 2005). The targets of the quinolones are topoisomerases. 
Topoisomerases are enzymes used in DNA replication that are responsible for DNA 
topology, meaning the correct modulation of chromosomal supercoiling during 
replication (Espeli and Marians 2004; Drlica, Malik et al. 2008; Sugino, Peebles et al. 
1977).  
In the same way that quinolones interfere with nucleic acid metabolism, rifamycin 
antibiotics inhibit RNA synthesis by tightly binding to RNA polymerase, thereby 
inhibiting the transcription of DNA to RNA (Campbell, Korzheva et al. 2001; 
Hartmann, Honikel et al. 1967). Rifamycins were discovered in 1957 and are most 
efficient against Mycobacteria for treatment of tuberculosis and leprosy (Sensi 1983).  
Different classes of antibiotics interfere with protein synthesis by binding either to the 
small (30S) or the large (50S) subunit of the ribosome and thereby inhibiting the 
translation of mRNA to protein. Antibiotics binding to the 30S subunit of the ribosome 
belong to the antibiotic families of tetracycline and aminocyclitol. Antibiotics binding 
to the large (50S) subunit include, among others, the classes of macrolides and 
amphenicol antibiotics (Mukhtar and Wright 2005; Katz and Ashley 2005). These are 
usually narrow spectrum antibiotics, which are effective only against specific bacteria. 
The aminoglycoside family of antibiotics however, is mostly effective against Gram-
negative bacteria and interferes with protein synthesis by binding to the 16S rRNA 
component of the small (30S) ribosome subunit (Mingeot-Leclercq, Glupczynski et al. 
1999).  
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Figure 1 shows the molecular structures of a few examples of antibiotics and the 
cellular process with which they interfere.  
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Molecular structures of representative antibiotics and the cellular process with which 
they interfere. The antibiotic classes are shown in parentheses.  
 
2.3 Criteria for a potential drug target? 
 
Antibiotic resistance is a natural process. When bacteria are exposed to an antibiotic, 
the susceptible cells will die. However, bacteria that carry certain genetic mutations or 
have received a gene that causes them to be resistant will survive and multiply.  
Eventually many if not all of the strains will be resistant. Thus new classes of 
antibiotics will also not be effective anymore after a certain time. Pathogens with 
multiple drug resistance spread rapidly and so far resistance has evolved for every 
main class of antibiotics (Walsh 2003; Walsh 2003a).  
A macromolecular target of an antibiotic, as the classical targets described above, has 
to fulfil at least two criteria. Firstly, on the basis of a genetic approach, the gene of the 
macromolecule has to be conserved among pathogens but absent in higher eukaryotes. 
Due to the genome sequencing possibilities and the ability to predict function from the 
sequence by using bioinformatics, genomes of bacteria can not only be screened for 
potential antibiotics but also for potential drug targets (Ji, Zhang et al. 2001; McDevitt 
and Rosenberg 2001; Walsh 2003). Secondly, a drug target has to be essential for the 
pathogen either in function or structure, meaning that binding of an antibiotic to the 
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target leads to breakdown of an essential cellular process and subsequently prevents 
cell growth or leads to cell death. Additionally, in order to reach a broad spectrum with 
the antibiotic, the target structure should be conserved among pathogens, but should 
not be a structural homologue to a protein of the host (Silver 2011). The absence of the 
gene in the human genome and the essential nature of the gene product for viability of 
the pathogen allows for specific targeting of the pathogen.  
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3 TonB-DEPENDENT UPTAKE OF SCARCE NUTRIENTS IN 
GRAM-NEGATIVE BACTERIA 
 
Gram-negative bacteria have developed a specific transport system for the uptake of 
scarce nutrients, such as iron and vitamin B12 across the outer membrane. This 
transport pathway includes a high-affinity, TonB-dependent outer membrane receptor 
(OMR), periplasmic binding protein (PBP), and an ATP-binding cassette (ABC) 
transporter in the inner membrane (Krewulak and Vogel 2008). The energy required 
for this transport is derived from the proton motive force of the cytoplasmic membrane 
and is transduced by the TonB system, which is composed of the three trans-membrane 
(TM) proteins TonB, ExbB and ExbD (Hancock and Braun 1976). TonB has three 
domains, a transmembrane domain, a central, flexible, proline-rich domain, which 
allows the protein to span the periplasmic space, and a globular, well-structured C-
terminal domain (CTD), which is responsible for interaction with the OMR (Evans, 
Levine et al. 1986). Despite some proposed model systems, the exact mechanism of 
how the energy is mediated via the TonB protein to the OMR still remains elusive.  
Iron is an essential micronutrient involved in various cellular processes like respiration 
and oxygen transport. The iron source is often limited and pathogen and host compete 
for iron sources. Iron can be bound in its oxidized form to the host proteins lactoferrin 
and transferrin, which bind OMR with high affinity (Khan, Shouldice et al. 2007). In 
addition to host derived iron sources, some pathogens secrete iron-binding proteins 
called siderophores into the host environment, which also bind the OMR with high 
affinity (Miethke and Marahiel 2007).  
 
3.1 TonB structure and interaction with the OMR 
 
In order to elucidate the mechanism of energy transduction via the TonB system and 
the interaction of TonB with the OMR, crystal structures and also an NMR solution 
structure of different lengths of the TonB-CTD from E. coli have been published 
earlier (Sean Peacock, Weljie et al. 2005; Chang, Mooser et al. 2001; Kodding, Killig 
et al. 2005; Koedding, Howard et al. 2004). 
The first TonB-CTD crystal structure reported, composed of the last 76 residues, 
revealed a novel fold (PDB: 1IHR) and is shown in Figure 2a. The structure contains 
one α-helix and a three-stranded antiparallel β-sheet, which suggests that TonB-CTD 
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dimerizes (Chang, Mooser et al. 2001). However, controversial results about the 
putative dimerization of TonB-CTD have been published depending on the distinct 
length of the CTD (Koedding, Howard et al. 2004). Subsequent TonB-CTD structures 
published, including the NMR solution structure (PDB: 1XX3) (Sean Peacock, Weljie 
et al. 2005) and a crystal structure of the last 92 residues of TonB-CTD are also shown 
in Figure 2 and suggest that the protein is monomeric in solution (PDB: 1U07), 
(Kodding, Killig et al. 2005). Interestingly, when the last 92 residues of TonB-CTD are 
crystallized they do indeed form a dimer (Figure 2b). Dynamic light scattering,
however, showed that the molecule is monomeric in solution, indicating that the 
dimerization might not describe the native state of the protein (PDB: 1U07) (Kodding, 
Killig et al. 2005). These results were further strengthened by Cys substitution 
experiments of the TonB-CTD, which revealed that a TonB dimer is probably not 
formed in vivo (Postle, Kastead et al. 2010). Interestingly, the NMR solution structure, 
consisting of the last 88 residues of TonB-CTD, shows significant differences 
compared to the crystal structures including an additional β-strand (PDB: 1XX3). 
Furthermore, the unstructured region could be defined in more detail and it is proposed 
that the region before Ser151 is unstructured in TonB from E. coli (PDB: 1XX3) (Sean 
Peacock, Weljie et al. 2005).  
 
 
 
 
 
 
 
 
 
 
Figure 2: 3D structure of E. coli TonB-CTD. a) First crystal structure of EcTonB-CTD showing 
the domain swapped protein as an intertwined dimer, residues 164 – 239. (PDB: 1IHR) (Chang 
et al., 2001). b) Crystal structure, residues 150 – 239. c) NMR Solution structure showing 
EcTonB-CTD as a monomer, residues 153 - 239 (PDB: 1XX3) (Sean Peacock, Weljie et al., 
2005). 
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The physical association of TonB with ExbB and ExbD via the transmembrane region 
have been described previously (Jaskula, Letain et al. 1994; Postle and Larsen 2007). 
The interaction of the well-structured TonB-CTD with the OMR has been studied 
intensively and several crystal structures of TonB-OMR complexes from E. coli have 
been published previously (PDB: 2GRX and 2GSK) (Pawelek, Croteau et al. 2006; 
Shultis, Purdy et al. 2006). The structure of the OMR FhuA-TonB complex (PDB: 
2GRX) (Pawelek, Croteau et al. 2006) of E. coli is shown in Figure 3.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Crystal structure of EcTonB-CTD (dark grey) in complex with the OMR FhuA (grey) 
(PDB: 2GRX) (Pawelek, Croteau et al., 2006). 
 
The structure of the OMR is well known and conserved among species. The structure 
is composed of 22 antiparallel β-strands localized in a β-barrel, and the periplasmic N-
terminal domain, called the cork or plug domain, is directed into to barrel. The well-
structured N-terminal domain contains the conserved TonB-box motif, which is 
responsible for binding to TonB-CTD (Krewulak and Vogel 2008; Ferguson, Kodding 
et al. 2001; Pawelek, Croteau et al. 2006; Yue, Grizot et al. 2003; Ferguson, 
Chakraborty et al. 2002). A strand exchange between one of the TonB-CTD β-strands 
and TonB-box is responsible for interaction of TonB with the OMR. The interaction 
between TonB-CTD and the TonB-box was also shown by NMR titration studies of 
TonB-CTD with the TonB-box peptide (Sean Peacock, Weljie et al. 2005; Pawelek, 
Croteau et al. 2006). Contradictory results have been published on the binding affinity 
of the interaction of TonB from E. coli with the OMR (Sean Peacock, Weljie et al. 
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2005; Freed, Lukasik et al. 2013). The binding affinity has been shown to be 
dependent on the specific OMR and varies between low affinity (μM range) and high 
affinity (nM) (Sean Peacock, Weljie et al. 2005; Freed, Lukasik et al. 2013). These 
results indicate that a detailed characterization of the interaction at the atomic level is 
controversial, and more experimental evidence is needed. 
Various models describing the energy transduction mechanism to the OMR have been 
discussed. However, the exact mechanism and the nature of the conformational change 
that occurs in TonB during energy mediation is still unknown (Larsen, Thomas et al. 
1999). The “TonB shuttle hypothesis” (Letain and Postle 1997), which assumed that 
energy is transduced by dissociation of TonB from the cytoplasmic membrane and 
association with the outer membrane via TonB-CTD was not supported, since later 
studies showed that TonB does not dissociate from the cytoplasmic membrane at any 
stage (Gresock, Savenkova et al. 2011; Kaserer, Jiang et al. 2008). Other approaches, 
like the propeller model published in 2001 and another rotation model published 
recently, proposed that energy is mediated by rotational motion to the OMR. TonB-
CTD would rotate in the periplasmic space and dimerize upon interaction with the 
TonB-box. However, as mentioned above, dimerization is probably not needed for 
energy transduction (Klebba 2016; Cascales, Lloubes et al. 2001). 
 
The exact mechanism of energy transduction via TonB remains elusive. The crucial 
role of TonB in the acquisition of iron and other scarce nutrients in Gram-negative 
bacteria and in virulence, as shown with mutational studies, make the TonB-system an 
attractive target for new-generation antibiotics (Beddek, Sheehan et al. 2004; Postle, 
Kastead et al. 2010). Furthermore, as a protein located in the periplasmic space of 
Gram-negative bacteria, it is probably more easily accessible by antibiotics. Therefore, 
detailed structural and functional knowledge about the protein including 
characterization of the interaction of TonB with the OMR at the atomic level should be 
acquired.  
 
?  
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4 THE CELL SHAPE DETERMINING PROTEINS MreB, MreC 
AND MreD 
 
The cell shape determining proteins MreB, MreC and MreD are part of a cytoskeletal 
associated complex and control cell morphogenesis in bacteria (Leaver and Errington 
2005). MreB, the bacterial homologue of actin has been widely studied. It forms an 
actin-like bacterial cytoskeleton along the membrane, and the crystal structure of MreB 
(PDB: 1JCE) resembles the structure of actin (Ji, Zhang et al. 2001; Jones, Carballido-
Lopez et al. 2001). MreB filaments rotate around the long axis of the cell and 
interestingly, the MreB movement is not dependent on polymerization of the protein 
but on the cell wall synthesis activity (van Teeffelen and Gitai 2011; Garner, Bernard 
et al. 2011; Dominguez-Escobar, Chastanet et al. 2011). It has been shown that MreB 
functions as a coordinator of proteins in cell wall synthesis by recruiting proteins of the 
cell wall synthesis machinery, like penicillin-binding proteins (PBPs), but also MreC 
and MreD to the locations of peptidoglycan insertion (van Teeffelen and Gitai 2011; 
White, Kitich et al. 2010). Beside MreB, however, the roles of MreC and MreD, which 
are also responsible for the characteristic cell shape of bacteria, remain to be 
elucidated. MreD and MreC are both transmembrane proteins. The integral membrane 
protein MreD has five transmembrane (TM) spanning domains and short regions 
consisting of about 8 residues that are located inside the cytoplasm. MreC, on the other 
hand, has only a short cytoplasmic tail followed by one TM helix and the major C-
terminal domain is located outside the cytoplasm (Lee and Stewart 2003). The crystal 
structure of MreC from Listeria monocytogenes revealed the dimeric structure of the 
protein (PDB: 2J5U) (van den Ent, Leaver et al. 2006) as shown in Figure 4. 
Dimerization is supposed to occur between the coiled-coil regions, located after the 
TM domain (Kruse, Bork-Jensen et al. 2005; van den Ent, Leaver et al. 2006). 
Interaction of MreC with the other cell shape determining proteins MreB and MreD 
has been shown previously (Lee and Stewart 2003; Kruse, Bork-Jensen et al. 2005; van 
den Ent, Leaver et al. 2006). Similar to MreB, MreC might function as a scaffold 
protein, which is involved in the correct positioning of proteins of the peptidoglycan 
synthesis machinery (White, Kitich et al. 2010; Divakaruni, Loo et al. 2005; 
Divakaruni, Baida et al. 2007). In the rod-shaped Bacillus subtilis, it has been shown 
that MreC is involved in peptidoglycan synthesis along the cylinder of the cell (Leaver 
and Errington 2005; Hayhurst, Kailas et al. 2008). 
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Mutational studies revealed, that both, MreC, as well as MreD are essential under 
normal growth conditions in rod-shaped bacteria (Lee and Stewart 2003; Kruse, Bork-
Jensen et al. 2005; Divakaruni, Baida et al. 2007; Land and Winkler 2011). Notably, a 
recent publication showed, that neither MreC nor MreD are essential for viability in 
spherical shaped S. aureus, therefore it can be assumed that neither of these proteins is 
involved in cell wall synthesis in coccoid cells including Staphylococci or Streptococci 
(Tavares, Fernandes et al. 2015).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Crystal structure of L. monocytogenes MreC, showing the dimeric whole 
extracytoplasmic domain including the coiled-coil domain. (PDB: 2J5U) (van den Ent et al., 
2006). 
 
4.1 MreC structures and interactions 
 
The crystal structures of MreC from the Gram-positive bacteria Listeria 
monocytogenes (PDB: 2J5U) (van den Ent, Leaver et al. 2006) and from Streptococcus 
pneumoniae (PDB: 2QF4, 2QF5) (Lovering and Strynadka 2007) have been published 
so far. The structure of MreC from L. monocytogenes consists of a long N-terminal α-
helix connecting the TM domain with the C-terminal domain, which is composed of 
two wings, each of them having 6 β-strands, arranged in two antiparallel β-sheets in 
the first wing and in a canonical β-barrel fold in the second wing, respectively (van den 
Ent, Leaver et al. 2006) (Figure 4). Furthermore, the structure revealed that MreC 
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dimerizes through hydrophobic interactions between leucine residues of the N-terminal 
α-helix (van den Ent, Leaver et al. 2006). Dimerization of MreC was also shown using 
size exclusion chromatography, and in vivo dimerization was shown by a bacterial 
two-hybrid system (van den Ent, Leaver et al. 2006). 
The S. pneumoniae MreC crystal structure, in which the N-terminal α-helix was 
omitted, was composed of two six-stranded β-barrels, a structure similar to MreC from 
L. monocytogenes.  (Lovering and Strynadka 2007). 
As described in Section 4, the two processes of cell wall synthesis and cell shape 
determination are linked. However, the role of MreC in cell wall synthesis is not yet 
fully understood. The structural features of MreC described above might be crucial for 
further, more detailed investigation of putative interactions of MreC with proteins 
involved in cell wall synthesis. Various studies about the interactions of MreC with 
proteins involved in peptidoglycan synthesis, in particular with penicillin-binding 
proteins (PBSs), revealed an interaction between these proteins in Caulobacter 
crescentus, B. subtilis, E. coli and Helicobacter pylori (El Ghachi, Mattei et al. 2011; 
Figge, Divakaruni et al. 2004; Divakaruni, Loo et al. 2005; van den Ent, Leaver et al. 
2006; White, Kitich et al. 2010). Bacterial two-hybrid system analysis revealed that 
MreC of B. subtilis physically associates with different PBPs and mutational studies 
showed that the C-terminal β-barrel domains of MreC are needed for these interactions 
(van den Ent, Leaver et al. 2006). Furthermore, the interaction of MreC with PBPs in 
C. crescentus has been shown with affinity chromatography of cell extracts as well as 
with a bacterial two-hybrid system (Divakaruni, Loo et al. 2005; White, Kitich et al. 
2010). Yeast-two hybrid system analysis showed that the minimal region of MreC 
needed for interaction with PBP2 in H. pylori, is located in the C-terminal domain and 
consists of residues 116 – 226 (El Ghachi, Mattei et al. 2011). Additionally, small 
angle X-ray scattering revealed that MreC and PBP2 form a stable complex, which is 
assumed to be essential for cell morphogenesis in vivo (El Ghachi, Mattei et al. 2011).  
Since MreC is proposed to have an essential role, not only in cell shape determination, 
but also in cell wall synthesis, in particularly regarding the putative interactions of 
MreC with PBPs, MreC might be an attractive target for new generation antibiotics. 
Additionally the localization of MreC, outside the cytoplasmic membrane makes the 
protein more accessible for drugs.  
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5 NMR FOR DETERMINATION OF PROTEIN STRUCTURE 
 
NMR spectroscopy has been used in this study to determine protein structures. Besides 
X-ray crystallography and cryo-electron microscopy, NMR spectroscopy is one of the 
main methods for determination of protein structures at high resolution. Structure 
determination by NMR will be described in the next sections.  
 
5.1 Preparation of protein samples for NMR 
 
Standard cloning techniques are used for the construction of an expression vector for 
recombinant protein expression and purification. For larger molecules, NMR requires 
uniformly isotope labelled (15N, 13C) protein samples for enhancement in resolution, 
and therefore the expression systems are often limited to expression in E. coli or a cell 
free protein expression system (LeMaster 1990; Clore and Gronenborn 1991; McIntosh 
and Dahlquist 1990; Vinarov, Lytle et al. 2004). However, isotope labelling can also 
be done using a baculovirus-insect cell expression system (Saxena, Dutta et al. 2012). 
For NMR studies, it might be necessary to produce a truncated version of the protein of 
interest (POI), for example a single domain of a protein, not only because structure 
determination by NMR is limited by molecular size, but also because unstructured or 
flexible parts might severely interfere with the quality of the spectra. The spectrum of a 
globular protein shows well-dispersed resonances, whereas the spectrum of an 
unstructured protein, shows resonances that lack dispersion and severely overlap, 
which makes spectral analysis difficult (Dyson and Wright 2004). Figure 5 shows a 
2D [1H, 15N]-HSQC spectrum of uniformly 15N-labelled TonB from H. pylori 
consisting of residues 36 - 285 (III). The flexible pro-rich domain severely interferes 
with the well-dispersed signals of the well-structured CTD of the protein in the range 
between 8.0 and 8.5 ppm and makes spectral analysis difficult.  
In general, NMR is a powerful tool to analyse the native state of a protein. Segmental 
isotopic labelling, which will be described later in this thesis, however, can be used to 
study individual protein domains of a protein with an unstructured region in a full 
length context.  
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Figure 5: 2D [1H, 15N]-HSQC spectrum of 15N-labelled TonB from H. pylori residues 36 – 285, 
showing the well-dispersed signals of the CTD and the severely overlapping signals of the 
unstructured domain between 8.0 and 8.5 ppm (III).  
 
It has to be considered that for NMR studies the protein must be stable in solution for 
the whole measurement time and at a concentration of > 50 μM (preferably between 
0.1 – 1 mM). A typical sample volume is 0.25 ml, and the pH of the sample has to be 
kept stable during the entire measurement time. Furthermore, samples with high ionic 
strength (> 100 mM) lead to longer pulse widths and increased sample heating, which 
influences the sensitivity of the measurement.  
 
As already mentioned, protein structure determination by NMR is limited by molecular 
size, and proteins > 25 - 30 kDa need specific labelling techniques, like fractional 
deuteration or amino acid selective labelling, to make spectral analysis possible (Lian 
and Middleton 2001), (Gardner and Kay 1998; Kainosho 1997). By selective 
protonation of methyl groups of deuterated samples, the source of proton-proton 
distance restraints can be partly restored. This is structurally interesting, since methyl 
groups are often located in the hydrophobic core (Rosen, Gardner et al. 1996) (Goto 
and Kay 2000). For selective protonation, protein overexpression is done in medium 
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containing D2O instead of H2O and protonated pyruvate as the only carbon source. 
Bacteria use pyruvate for the biosynthesis of Ala, Val, Leu and Ile. Therefore, the 
methyl groups of these amino acids will stay protonated (Rosen, Gardner et al. 1996).  
However, besides the extensive resonance overlap problem for proteins > 25 – 30 kDa, 
there is an additional issue; increased molecular size leads to line broadening due to 
longer correlation time and thereby to decreased resolution. Therefore, the transverse 
relaxation optimized spectroscopy (TROSY) approach is usually used to study larger 
proteins (Luginbuhl, Pervushin et al. 1997).  
 
5.2 Structure determination 
 
NMR allows the elucidation of the three dimensional (3D) structure of proteins in the 
solution phase. The first step in structure determination using NMR spectroscopy is the 
chemical shift assignment of backbone and side chain resonances. Almost complete 
chemical shift assignment of 1H, 13C and 15N resonances is needed for subsequent 
calculation to obtain a reliable structure (Jee and Guntert 2003). For chemical shift 
assignment, a series of double- and triple resonance NMR experiments of the 13C, 15N-
labelled sample is recorded and data analysis is done using a combined approach 
(Ikura, Kay et al. 1990; Sattler, Schwendinger et al. 1995) (Sattler and Schleucher, 
1999). Besides the specific resonance assignment, structural restraints, traditionally 
distance restraints, derived from 13C- and 15N-edited 3D NOESY spectra are required 
for structure calculation. Nuclear Overhauser effects (NOEs) are observations of 
nuclear dipole cross relaxation where magnetization is not transferred through bonds, 
but transferred through space and NOE cross peaks are generated during the specific 
mixing time. The intensity of an NOE signal is inversely proportional to the distance r 
between the two proton nuclei (∼r-6). Therefore only protons closer than ∼ 6 Å give a 
detectable correlation. For structure calculations, NOEs are classified upon intensity as 
strong/medium/weak and each class has an upper limit distance restraint (Guntert 
2009). For NMR-based protein structure calculation, various programs, such as 
CYANA (Guntert 2004; Herrmann, Guntert et al. 2002) and ARIA (Habeck, Rieping 
et al. 2004) are available. For this thesis, the CYANA program was used. In CYANA, 
the assignment of NOEs is based on network anchoring (Herrmann, Guntert et al. 
2002). In the network anchoring approach several NOEs between two residues have to 
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be observed for the assignment, meaning that a single NOE is not sufficient for 
observation of NOE between two residues (Herrmann, Guntert et al. 2002). For the 
structure calculation using CYANA, the correctness and (near) completeness of the 
resonance assignment is crucial, since missing or wrong assignments make the NOE 
assignment unreliable and influences the correctness of the initial structure model, 
which is used to filter out NOE assignments (Jee and Guntert 2003). Typically, seven 
cycles of automated NOE assignments, followed by a structure calculation are 
performed. After the first cycle the overall structure does not change anymore but NOE 
assignment and root mean square deviation (RMSD) is improved. If all distance and 
dihedral angle restraints are in agreement with the calculated structure the CYANA 
target function is 0 (Guntert 2004).  
In addition to distance restraints, other types of restraints, such as dihedral angle 
restraints, which can be based on calculated chemical shifts (Shen, Delaglio et al. 
2009) or measured through J-couplings, can be used for structure calculation. 
Furthermore, additional input data can be provided for structure determination (Guntert 
1998), including secondary structure information, e.g. calculated from chemical shift 
(Wishart and Sykes 1994), hydrogen bond restraints (Cordier and Grzesiek, 1999) or 
orientational restraints, based on residual dipolar coupling (Tjandra, Omichinski et al. 
1997) between two spins, which provide long-range distance structural information of, 
e.g., multi-domain proteins. Since molecules in solution are dynamic, conformational 
exchange occurs and the structure determination based on NMR data describes an 
average of possible conformations. Typically a set of 20 conformers is calculated.  
The possibility to study molecules in solution is probably the main advantage of NMR 
and makes it a powerful and efficient tool for studying protein dynamics and 
interactions, thereby providing information to understand protein function.  
After the structure calculation, the 20 conformers of the structure have to be refined. 
This is done using full molecular dynamics force fields in explicit water solvent, by 
which physically more realistic structures are obtained that can be used for further 
applications (Linge, Williams et al. 2003; Xia, Tsui et al. 2002). The last step in 
structure determination is quality control and validation of structure conformers. 
Various bioinformatics tools are available for quick and reliable structure validation. 
The refined solution NMR structures can be evaluated, e.g. by PSVS (Bhattacharya, 
Tejero et al. 2007), PROCHECK or WHAT-CHECK (Hooft, Vriend et al. 1996). 
Figure 6 shows the typical steps needed in protein structure determination by NMR 
?? ?
spectroscopy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Schematic overview structure determination by NMR spectroscopy. 
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5.3 Segmental isotopic labelling 
 
When studying proteins with molecular weights > 25 – 30 kDa, two factors make 
NMR studies and spectral analysis more difficult: (i) the large number of residues 
contribute to severe overlap of resonances and increase the complexity of the spectra 
and (ii) the longer correlation times lead to faster transverse relaxation and broader 
linewidths and decreased resolution. The broadening of the resonances can be 
alleviated by the TROSY approach (Pervushin, Riek et al. 1997). Segmental isotopic 
labelling, however, where only a part of the protein is stable isotope labelled, is an 
attractive tool to decrease the complexity of NMR spectra when studying larger 
proteins, since specific regions of the protein can be selectively investigated. 
Segmental isotopic labelling can be used for various applications, such as assignment 
and structure determination of larger proteins and structural studies of single domains 
in a full-length context. Furthermore segmental labelling can be used to investigate 
protein-ligand interactions of large or multi-domain proteins, e.g. by segmental 
labelling of a known epitope, the interaction site with a ligand in a full-length context 
can be investigated. Additionally, by isotope segmental labelling, ligand perturbation 
of multi-domain proteins can be observed.  
In order to join together the protein segments, intein mediated protein splicing can be 
performed. Isotopic segmental labelling can be performed in vitro. Then the two 
protein precursors, N- and C-precursors, fused with N- and C-inteins, respectively, are 
expressed individually, and protein splicing is done in vitro (Otomo, Teruya et al. 
1999; Yagi, Tsujimoto et al. 2004). However, segmental isotopic labelling can also be 
performed in vivo by sequential co-transformation of cells with two plasmids, each 
containing either the N- or C-precursor fragments, and a medium exchange for isotope 
labelling in between the expressions (Zuger and Iwai 2005). Thereby, structural 
investigations by NMR of large multiple domain proteins up to 140 kDa could be 
performed (Muona, Aranko et al. 2008; Minato, Ueda et al. 2012).  
 
5.3.1 Protein trans splicing for segmental isotopic labelling 
 
Intervening protein sequences (intein) were initially reported in 1990 (Kane, 
Yamashiro et al. 1990; Hirata, Ohsumk et al. 1990). Inteins are responsible for protein 
splicing, an autocatalytic post-translational modification, where the intein excises itself 
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from the precursor protein and simultaneously joins the flanking regions, called N- and 
C-exteins, by creating a peptide bond (Perler, Davis et al. 1994; Hirata, Ohsumk et al. 
1990; Kane, Yamashiro et al. 1990; Cooper, Chen et al. 1993). Protein splicing occurs 
as a traceless process, needing no cofactor or energy source (Hirata, Ohsumk et al. 
1990; Kane, Yamashiro et al. 1990). The mechanism of protein splicing has been 
described in 1996 (Xu and Perler 1996) and is dependent on the conserved regions. To 
mention only a few of them, the mechanism is dependent on the first residue of the 
intein, that is by definition either a Cys or a Ser and the last two residues, His and Asp, 
at the C-terminus of the intein (Xu and Perler 1996; Pietrokovski 1994; Perler, Olsen et 
al. 1997). The sequence conservation as well as structural conservation of inteins have 
been studied extensively and are not discussed in this thesis in detail (Pietrokovski 
1994; Perler, Olsen et al. 1997). Inteins are structurally conserved and their protein 
fold resembles the structure of the Hedgehog protein C-terminal domain (Pietrokovski 
2001; Oeemig, Aranko et al. 2009). For protein splicing to occur, the intein sequence 
and a nucleophilic residue (Cys, Ser or Thr) at the first position of the C-extein have 
been shown to be the only criteria required (Cooper, Chen et al. 1993; Noren, Wang et 
al. 2000).  
Inteins are observed in all three domains of life (archaea, bacteria and eukarya), 
however only in unicellular organisms (Shub and Goodrich-Blair 1992; Lazarevic, 
Soldo et al. 1998). Inteins have also been identified in viruses and bacteriophages 
(Pietrokovski 1998). The size of inteins varies and can consist of about 130 to about 
1000 residues (Evans, Benner et al. 1999; Perler 2002). The size is dependent on 
whether the intein contains an inserted endonuclease domain. Because of the 
endonuclease domain most of the inteins are bifunctional. The endonuclease domain, 
however, is not needed for splicing activity (Wu, Hu et al. 1998; Chong and Xu 1997; 
Telenti, Southworth et al. 1997), and it is inserted into the sequence in a way that it 
does not influence the splicing reaction, which is performed by the N- and the C-
terminal parts of the intein (Duan, Gimble et al. 1997). The endonuclease domain is 
proposed to be important for spreading intein coding sequences by horizontal gene 
transfer (Roberts and Macelis 1997). Inteins lacking an endonuclease domain are 
usually small in size, about 150 residues, and they function as split inteins.  
Split inteins occur naturally (Caspi, Amitai et al. 2003). The N- and C-intein parts of a 
split intein are expressed by two different genes (Wu, Hu et al. 1998; Gorbalenya 
1998). The individual intein parts are unfolded and therefore inactive. However upon 
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association they fold into the correct 3D structure and become functional (Zheng, Wu 
et al. 2012). Interestingly, engineered split inteins were reported (Mills, Lew et al. 
1998; Southworth, Adam et al. 1998) before the discovery of natural split intein coding 
sequences in cyanobacteria DnaE gene in 2003 (Caspi, Amitai et al. 2003). Artificially 
split inteins have been designed by splitting the intein at the same site where natural 
split inteins contain a split site, usually they are split where the endonuclease domain is 
inserted (Derbyshire, Wood et al. 1997; Hiraga, Derbyshire et al. 2005; Wu, Xu et al. 
1998). Split inteins perform protein trans splicing, and they have considerable 
potential as bioengineer tools for a number of biotechnological applications, such as 
segmental isotopic labelling, intein-mediated or site specific modification (Iwai, Zuger 
et al. 2006; Aranko, Zuger et al. 2009). 
Inteins from extremely halophilic archaea, such as PolII and CDC21 from 
Halobacterium salinarum, have been reported previously (Ellila, Jurvansuu et al. 2011; 
Sakakibara, Han et al. 2008). These inteins are unfolded and therefore inactive under 
low salinity conditions, however, under high salinity conditions, they fold and 
spontaneously perform protein splicing (Reitter, Cousin et al. 2016). In this study, the 
artificially split intein, MCM2 intein from Halorhabdus utahensis, was used for 
segmental isotopic labelling (III). Protein trans splicing can be induced by increasing 
the salt concentration.  
 
5.4 Soluble protein expression for NMR structural studies 
 
Despite various bioinformatics tools (IUPred (Dosztanyi, Csizmok et al. 2005; 
Dosztanyi, Csizmok et al. 2005a), PONDR (Obradovic, Peng et al. 2003), ESpritz 
(Pollastri, Przybylski et al. 2002)), disordered or highly flexible regions cannot always 
be predicted accurately from the sequence. As already mentioned above, NMR is a 
powerful tool to analyse the native state of a protein. Using NMR, the folding state of a 
protein can be efficiently determined by measuring a simple 1D 1H NMR spectrum. 
However, only a gross estimate about secondary and tertiary structure can be made 
from a 1D 1H NMR spectrum, and with increasing protein size additional dimensions 
have to be added to alleviate crowding in the spectrum. A globular uniformly 
isotopically labelled protein shows well-dispersed signals in a 2D [1H, 15N]-HSQC 
spectrum, whereas an unfolded protein, or a protein containing disordered regions, 
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shows severe signal overlap in the random coil region between 8 and 8.5 ppm of the 1H 
dimension, which is also shown in Figure 5.  
Therefore, highly disordered regions in a protein often severely hinder spectral 
analysis, and re-cloning of the protein construct, in order to get rid of the disordered 
domains, might be considered. Disordered regions are often found at the N- and C-
termini of a protein and might be omitted when doing structural investigations by 
NMR.  
For structural investigation of proteins by NMR or X-ray crystallography, production 
of soluble proteins is essential. Although production of recombinant isotopically 
labelled proteins is not completely restricted to production in E. coli, the advantages of 
protein expression in an E. coli host system are well known and make E. coli, if 
possible, the preferred expression system. However, protein expression of a foreign 
gene in E. coli differs from the expression of the same protein in its natural host 
regarding, e.g. redox-potential, pH and folding mechanisms (Rosano and Ceccarelli 
2014). These aspects can induce instability and aggregation of the POI in E. coli and 
might lead to expression of insoluble protein (Hartley and Kane 1988). Additional 
factors, such as the correct formation of disulphide bonds, which is dependent on the 
redox-potential and particular enzymes (Messens and Collet 2006), and the 
requirement of co-chaperones during protein folding (Hartl and Hayer-Hartl 2002) also 
influence the solubility of a protein expressed in a foreign organism. The exact 
mechanisms of how these factors influence protein solubility have been studied 
extensively and will not be discussed here (Derman, Prinz et al. 1993; Hartley and 
Kane 1988). 
For some proteins, which tend to be expressed in an insoluble form, simply lowering 
the expression temperature might improve soluble protein expression. Lower 
temperatures reduce the production rate and thereby give newly transcribed proteins 
the time to fold properly (Vera, Gonzalez-Montalban et al. 2007). However, lowering 
the incubation temperature may not be sufficient to obtain an adequate amount of 
soluble protein. Therefore, fusion-proteins, such as the maltose-binding protein (MBP) 
(Kapust and Waugh 1999), thioredoxin (Trx) (LaVallie, DiBlasio et al. 1993), 
glutathione S-transferase (GST) (Smith and Johnson 1988) and small ubiquitin 
modifying protein (SUMO) (Butt, Edavettal et al. 2005; Malakhov, Mattern et al. 
2004), which work as fusion enhancers (Hammarstrom, Hellgren et al. 2002), might be 
attached to the N-terminus of the POI. For most of these proteins, it remains elusive 
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why they work as solubility enhancers. MBP, however, was shown to have an intrinsic 
chaperone activity (Kapust and Waugh 1999). Despite their ability to enhance soluble 
protein expression in E. coli, these proteins do not possess similar molecular size, 
structure or function. However, it has been proposed that they act as solubility 
enhancers because the highly conserved structures of these proteins, when used as N-
terminal fusions, might be crucial for stabilization of the recombinant protein and 
might promote folding of the POI (Butt, Edavettal et al. 2005; Arechaga, Miroux et al. 
2003).  
Once the protein is expressed in a soluble form, the cleavage of the fusion-protein from 
the POI is essential for further structural investigation by NMR or X-ray 
crystallography, since the uncleaved fusion-protein might interfere with functional or 
structural characteristics of the recombinant protein.  
 
5.4.1 Tandem SUMO fusion vectors for soluble protein expression 
 
The covalent attachment of SUMO to a protein is a post-translational modification and 
part of various cellular processes. The mechanism of SUMO conjugation to a target 
protein has been described previously (Desterro, Thomson et al. 1997; Hay 2005). 
SUMO is produced as a precursor and activated by proteolytic cleavage. The 
mechanism involves a SUMO specific protease, which is also responsible for de-
conjugation of SUMO, and the three enzymes, activating enzyme (E1), conjugating 
enzyme (E2) and ligase (E3), that catalyse the mechanism, including the 
transesterification step (Hay 2005; Butt, Edavettal et al. 2005). The yeast homologue 
of SUMO, Smt3, and two SUMO specific proteases, ubiquitin-like proteases (Ulp) 
Ulp1 and Ulp2, have been characterized in Saccharomyces cerevisiae (Li and 
Hochstrasser 2000; Li and Hochstrasser 1999). For activation, the SUMO specific 
protease reveals the C-terminal glycine which is covalently linked to the side chain of a 
conserved lysine in the target protein (Hay 2005). 
Mutational studies revealed that SUMO conjugation is essential for cell cycle 
progression (Seufert, Futcher et al. 1995). Furthermore, SUMO modification is 
required to control subcellular transport of proteins, in particular, the transport of 
nuclear proteins to the nuclear pore complex (NPC). For example, the localization of 
RanGAP1 is dependent on SUMO modification, which also facilitates the interaction 
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with other nuclear proteins (Rodriguez, Dargemont et al. 2001; Joseph, Tan et al. 2002; 
Pichler and Melchior 2002). Additionally, SUMO modification is crucial for 
transcriptional regulation, it can induce transcriptional activation but more often it 
leads to transcriptional repression (Gill 2004). Furthermore, SUMO modification leads 
to stabilization of certain proteins (Hay 2005). 
The SUMO fusion technology has been used for improved soluble protein expression 
for more than a decade (Malakhov, Mattern et al. 2004). Proteins expressed as SUMO-
fusion proteins can be translocated to the nucleus and thereby the expressed protein is 
better protected from proteolytic degradation in the cytosol (Butt, Edavettal et al. 
2005). The ubiquitin structure is highly conserved in the SUMO protein (Bayer, Arndt 
et al. 1998), and as a protein containing a highly hydrophobic core it has been shown to 
have fast folding kinetics (Khorasanizadeh, Peters et al. 1996). Therefore SUMO 
probably improves solubility through stabilization and by providing a nucleus of 
folding, which promotes folding of the recombinant protein (Malakhov, Mattern et al. 
2004; Butt, Edavettal et al. 2005).  
For structural investigations of the POI, the fusion-protein has to be cleaved from the 
recombinant protein after successful soluble expression. Various enzymes are available 
for proteolytic cleavage of the recombinant protein, like thrombin protease, tobacco 
etch virus (TEV) protease or factor xa (Jenny, Mann et al. 2003). Besides possible 
challenges related to cleavage of the fusion-protein, such as precipitation of the POI or 
inefficient cleavage, which often require optimization of the cleavage step, one main 
problem is that non-native residues are often incorporated into the sequence of the POI 
at the N-terminus. For example, thrombin cleaves at the arginine residue in the 
sequence LVPRGS, leaving GS as non-native residues at the N-terminus of the POI 
(Jenny, Mann et al. 2003). These additional residues might interfere with the structure 
or function of the POI.  
However, by fusion of SUMO directly to the N-terminus of the POI and subsequent 
cleavage of SUMO by Ulp1 protease, native-like POI is generated since Ulp1 
specifically recognizes the 3D structure of the SUMO fusion instead of a specific 
amino acid sequence (Butt, Edavettal et al. 2005; Malakhov, Mattern et al. 2004). 
Another advantage of the Ulp1 protease is its high efficiency and robustness (Butt, 
Edavettal et al. 2005). 
The use of a SUMO fusion-protein in combination with solubility enhancers, such as 
MBP, trx and GST, was tested on TonB-CTD from different organisms for improved 
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soluble expression (II). For the specific cleavage, the proteolytic domain of Ulp1 was 
used and different linkers between the N-terminus and the fusion-protein were tested to 
investigate the efficiency of the Ulp1 protease (II).  
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6 AIMS OF THE STUDY 
 
The experimental part of this thesis mainly consists of molecular biology, protein 
biotechnology and biochemistry including expression and purification, and NMR 
spectroscopic studies of two bacterial proteins, MreC and TonB. MreC is from the 
Gram-positive model bacterium Bacillus subtilis and TonB from the pathogenic Gram-
negative bacterium Helicobacter pylori. NMR spectroscopy was applied to determine 
structures, interactions and dynamics of these proteins in order to better understand 
their functions. Additionally, TonB was used as a model protein for biotechnological 
applications, which include (i) the design of tandem SUMO fusion vectors for more 
soluble protein expression and (ii) studies with halophilic inteins from Haloarchaea to 
show their practical use as bioengineering tools, in particular for isotopic segmental 
labelling of TonB by protein trans splicing (PTS). These applications might strongly 
support structural investigations of proteins by NMR, which are difficult to study using 
standard techniques.  
 
The specific aims of these studies were to:  
(i) Determine the NMR solution structure of the extracytoplasmic domain of 
MreC from B. subtilis and interactions of MreC with the penicillin-binding 
protein (PBP)  (I, V, this thesis). 
(ii) Determine the NMR solution structure of the C-terminal domain of TonB 
from H. pylori (IV, III).  
(iii) Evaluate the use of tandem SUMO fusion vectors for more soluble protein 
expression with TonB as a model protein (II). 
(iv) Develop a method for traceless segmental isotopic labelling of TonB 
protein by salt induced protein trans splicing using halophilic inteins (III). 
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7 EXPERIMENTAL PROCEDURE 
 
In this section a summary of the methods and materials used during these studies is 
given. For more detailed information, the reader is referred to the individual 
publications and manuscripts.  
 
7.1 Molecular cloning 
 
7.1.1 TonB constructs 
 
Constructs of different lengths of H. pylori TonB (HpTonB) were created for 
determination of the solution structure, assessing the solubility and for segmental 
isotopic labelling by protein trans-splicing using inteins from halophilic archaea.  
 
7.1.1.2 Constructs for structure determination 
 
For determination of the solution structure of the C-terminal domain (CTD) of TonB, a 
shorter construct pACRSF01 (H6-SMT3-HpTonB-92) and a longer construct, 
pBHRSF159 (H6-SMT3-HpTonB-107) were created. The fragment encoding HpTonB-
CTD domains of different lengths were amplified by PCR from genomic H. pylori 
DNA and inserted into the backbone vector pHYRSF53 (Addgene 64696, (II)) 
resulting in constructs pACRSF01 and pBHRSF159.  
 
7.1.1.3 Construct for assessing soluble expression of HpTonB-CTD 
 
In order to assess soluble expression of HpTonB, the plasmid pACRSF02 (H6-SMT3-
MBP-HpTonB-92) was generated. The encoding sequence of HpTonB-92 was 
amplified by PCR from genomic H. pylori DNA and inserted into the backbone vector 
pLJSRSF7 (Addgene 64693) (II).  
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7.1.1.4 Constructs for protein ligation by salt induced PTS using HutMCM2 
 
For the N-terminal precursors, the plasmids pACRSF5 (HpTonB(36-154)-IntN-H8) and 
pJTRSF9 (HpTonB(36-154(K154R))-IntN-H8) were constructed (III). pJTRSF9 
contains Arg154 at the -1 position of the junction sequence instead of the native 
Lys154. For the C-terminal precursor, the plasmid pBHRSF165 (H6-IntC-
HpTonB(155-285)) was created (III). For comparison of the segmentally isotope 
labelled protein with the uniformly labelled full length protein, plasmid pACRSF4 (H6-
Smt3-HpTonB(36-285) (III) was constructed.  
 
7.1.2 MreC constructs 
 
7.1.2.1 Construct for structure determination 
 
For determination of the solution structure of the major extracytoplasmic domain of B. 
subtilis MreC (BsMreC (104 – 279)), the plasmid pRS077, containing an N-terminal 
hexahistidine tag, a glutathione S-transferase (GST) fusion tag and a thrombin 
cleavage site and BsMreC (104-279), was created. The fragment encoding the 
extracytoplasmic domain of BsMreC was amplified from genomic B. subtilis DNA and 
inserted into the pGEX-2T (GE Healthcare Life Sciences) vector (I and V).  
 
7.1.2.2 Constructs for interaction studies of MreC with PBP2a 
 
7.1.2.2.1 Constructs for NMR titration studies 
 
For NMR titration studies of BsMreC with B. subtilis PBP2a (BsPBP2a), constructs 
containing the following residue ranges were created: For BsMreC: 1) BsMreC (104 – 
279) (I and V), 2) BsMreC (25 – 279) and 3) BsMreC (104 – 290). For BsPBP2a: 1) 
BsPBP2a (43 – 689) and 2) BsPBP2a (60 – 689).  
The sequences encoding these domains were amplified by PCR from genomic B. 
subtilis DNA and inserted into pGEX-2T (GE Healthcare Life Science) vectors. The 
constructs were expressed as GST-fusion proteins containing a thrombin cleavage site.  
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7.1.2.2.2 Constructs for Bacterial two-hybrid system 
 
For bacterial two-hybrid assay, the BACTH system kit (Euromedex) was used. 
Constructs containing the following residue ranges of BsMreC were used: 1) Full-
length (1 – 290), 2) C-terminally truncated construct (1 – 279) and two constructs 
without the coiled-coil domain, 3) (1 – 23, 104 – 290) and 4) (1 – 23, 104 – 279). The 
sequences encoding these domains were amplified by PCR from genomic B. subtilis 
DNA and inserted into pUT18 vectors (BACTH system kit (Euromedex)) to create 
pUT18-MreC fusion constructs.  
The sequence encoding BsPBP2a (1 – 716) was amplified by PCR from genomic B. 
subtilis DNA and inserted into a pKT25 vector (BACTH system kit (Euromedex)) to 
create pKT25-PBP2a fusion constructs. 
 
7.2 Protein expression 
?
7.2.1 Expression of TonB-CTD 
 
7.2.1.1 Unlabelled and 15N, 13C labelled TonB-CTD samples 
 
Expression of unlabelled TonB proteins was done in E. coli ER2566 competent cells, 
which were grown at 37 °C in LB medium, supplemented with 25 μg/ml kanamycin. 
For stable isotope labelled constructs, protein expression was done in M9 medium 
containing 15NH4Cl and 13C-D-glucose as sole nitrogen and carbon sources, 
respectively. When the OD600 reached ~ 0.6, protein expression was induced with a 
final concentration of 1 mM isopropyl-β-D-thiogalactoside (IPTG). The cells were 
grown for an additional 4 h at 37 °C before they were harvested by centrifugation at 
4,900 ×g at 4 °C for 10 min. The cell pellet was resuspended in 300 mM NaCl, 50 mM 
NaPi buffer with pH 8.0 (Buffer A) and either used immediately or stored at – 70 °C 
until protein purification.  
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7.2.2 Expression of MreC and PBP2a proteins 
 
 
7.2.2.1 Unlabelled MreC, PBP2a and 15N, 13C-labelled MreC constructs 
 
Expression of MreC constructs was done in E. coli BL21(DE3) competent cells, which 
were grown in LB medium at 37 °C supplemented with 100 μg/ml ampicillin. For 
stable isotope labelled proteins, the cells were grown in M9 medium containing 
15NH4Cl2 and 13C-glucose as sole nitrogen and carbon sources, respectively. The cells 
were grown at 30 °C until the OD600 reached ~ 0.6, and protein expression was induced 
with a final concentration of 0.5 mM IPTG. Cells were grown overnight at 25 °C 
before they were harvested by centrifugation at 4,900 ×g for 10 min at 4 °C. The cells 
were resuspended in 5 ml 1 × PBS and either used immediately for further purification 
or stored for purification at -70 °C. 
 
7.3 Protein purification 
 
7.3.1 Purification of TonB protein constructs 
 
Cells were disrupted either by ultrasonication or in an Emulsiflex C3 homogenizer and 
cell debris was removed by centrifugation. The supernatant was loaded on a His-Trap 
HP column (GE Healthcare) or in the case of BHRSF159 on a His-Trap Excel column 
(GE Healthcare) and unbound protein was removed by washing the column with 
Buffer A. Bound protein was eluted from the column with buffer containing 300 mM 
NaCl, 50 mM NaPi and 250 mM Imidazole (pH 8.0) (Buffer B). The fractions 
containing the protein were pooled and dialyzed against 1 ×PBS. The dialyzed protein 
was digested with 0.1% Ulp1 in the presence of 1 mM DTT. After the digestion, the 
protein was separated from the H6-Smt3 fusion tag by a second IMAC round. The flow 
through fractions containing the protein were pooled and dialysed against 20 mM NaPi 
(pH 6.0) buffer (NMR buffer). The protein was concentrated using a centrifugal 
concentration device and stored at – 70 °C. 
For the proteins used for segmental isotope labelling (N- and C-precursor), only the 
first purification step was performed using a His-Trap HP column (GE Healthcare). 
Bound protein was eluted with Buffer B and the fractions containing the protein were 
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pooled and dialysed against 1 ×PBS. The dialysed protein was concentrated using a 
centrifugal concentration device and stored at – 70 °C.  
 
7.3.2 Purification of MreC and PBP2a protein constructs 
 
Cells were disrupted either using a French press or by ultrasonication. Cell debris was 
removed by centrifugation and the supernatant was loaded on a Glutathione-Sepharose 
4 Fast Flow column (GE Healthcare). Unbound protein was removed by washing the 
column with 1 ×PBS. To separate the protein from the GST-purification tag, thrombin 
digestion was done overnight at room temperature by addition of thrombin protease 
(GE Healthcare) at a concentration of 50 u / ml column material. Digested protein was 
eluted from the column with 1 ×PBS. The elution fractions containing the protein were 
pooled and concentrated using a centrifugal concentration device. A second 
purification step using a Superdex 75 gel filtration column (GE Healthcare) was 
performed. The column was washed with 1 ×PBS. The elution fractions containing the 
protein were combined and concentrated using a centrifugal concentration device. 
During the concentration procedure a buffer exchange from 1 ×PBS to 20 mM NaPi 
buffer, pH 6.5 (NMR buffer) was performed. The protein was either used immediately 
or stored at – 70 °C.  
 
7.4 Segmental isotopic labelling by protein trans-splicing 
 
The separately purified precursors in 1 ×PBS were mixed at a molar ratio of 1 : 1 in 
dialysis tubing and dialysed against high salt buffer (0.5 M NaPi, 3.5 M NaCl, pH 7.0) 
in the presence of 0.5 mM tris(2-carboxyethyl)phosphine (TCEP) for 16 to 40 h. The 
reaction was stopped by diluting the reaction mixture to a final concentration of 50 
mM NaPi, 150 mM NaCl. The ligated protein was separated from the intein and 
remaining precursors by a second IMAC purification using a HisTrap HP column (GE 
Healthcare). The flow through fractions containing the protein were pooled and 
dialysed against 20 mM NaPi, pH 6.0 for NMR analysis. 
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7.5 Bacterial two-hybrid system 
 
A Bacterial Adenylate Cyclase Two-Hybrid System Kit (BACTH System Kit, 
Euromedex) (Karimova, Pidoux et al. 1998) was used for interaction studies of 
BsMreC with BsPBP2a. Protein interaction shown by a bacterial two-hybrid system is 
based on the idea that the catalytic domain of adenylate cyclase (CyaA), which is 
composed of two fragments called T18 and T25, is not active when the fragments are 
dissociated from each other. However, when two proteins, which are fused separately 
to each of the fragments, associate, thereby bringing together the two fragments of the 
CyaA, CyaA is activated and cyclic AMP (cAMP) is produced.  cAMP binds to the 
catabolite activator protein (CAP), which, in complex with cAMP, is a regulator of 
gene transcription and positively regulates the expression of β-galactosidase. Since the 
CyaA has to be in the cytoplasm, MreC-T18 constructs containing the transmembrane 
domain (residues 1-23) and the extracytoplasmic domain (residues 104-279 or 104-
290) were created. The plasmids were co-transformed into competent BTH101 E. coli 
cells, which were plated on LB agar plates containing X-gal, IPTG and the appropriate 
antibiotics (kanamycin and ampicillin). The plates were incubated at 30 °C for 43 h. 
Both fragments T18 and T25 are under the transcriptional control of a lac promoter and 
therefore screening for blue colonies was done. The competent BTH101 E. coli cells 
were prepared according to the Hanahan method (Hanahan 1983).  
 
7.6 Bocillin FL stain of PBP2a 
 
In order to analyse the activity and folding status of BsPBP2a, fluorescently labelled 
penicillin, called Bocillin FL (Invitrogen) was used. Bocillin FL covalently binds to 
PBP2a and was therefore used for staining of active BsPBP2a (Zhao, Meier et al. 
1999). Three different concentrations of BsPBP2a (43 – 689), 100 μg, 10 μg and 1μg in 
100 μl 20 mM potassium phosphate buffer (pH 7.5) were incubated with 1 μl (10 μg) 
Bocillin FL for 30 min at 35 °C. The reaction was analysed on SDS-PAGE and 
visualized using an Argon laser imager (488 nm) (Amersham Biosciences, Typhoon 
9400). In order to check the size of the protein, the gel was afterwards stained with 
Coomassie Blue.  
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7.7 NMR studies 
 
7.7.1 NMR measurements 
 
NMR measurements for all TonB proteins were performed on a Bruker AVANCE III 
850 MHz spectrometer equipped with a cryogenically cooled probe head. The sample 
concentrations varied between 0.2 mM for segmentally isotope labelled proteins and 
0.5 mM for proteins used for structure determination in 20 mM NaPi buffer, pH 6.0 at 
298 K.  
NMR measurements for MreC proteins were performed on a Varian INOVA 600 MHz 
or 800 MHz both equipped with a cryogenically cooled probe head. The protein 
concentration for structure determination and relaxation studies was 0.5 mM in 20 mM 
NaPi buffer, pH 6.5 at 308 K.  
All NMR samples contained 7 – 10% D2O. 
For resonance assignment of both TonB and MreC proteins, a typical set of standard 
resonance spectra was recorded: [1H, 15N]-HSQC, [1H, 13C]-HSQC, HNCO, HNCA, 
HN(CO)CA, CBCA(CO)NH, HNCACB, HN(CA)CO, CC(CO)NH, HCC(CO)NH, 
HBHA(CO)NH, H(C)CH-COSY and 15N-edited TOCSY with 90 ms mixing time (for 
HpTonB (179-285)) (Permi and Annila, 2004), (Sattler, Schwendinger et al. 1995). 
The chemical shift assignments of the side chains of the aromatic residues were based 
on (HB)CB(CGCD)HD, (HB)CB(CGCDCE)HE, CT-[1H, 13C]-HSQC and 13C-edited 
NOESY-HSQC spectra.  
The relaxation measurements to study protein dynamics of MreC (104 – 279) were 
performed at a proton frequency of 800 MHz on a Varian INOVA at 303 K. T1(15N)-
relaxation rates were determined using 10 different durations of the delay T: 0.01, 
0.07, 0.15, 0.25, 0.47, 0.67, 0.91, 1.11, 1.31 and 1.51 s. For T2(15N)-relaxation rates 7 
different durations of the delay T were used: 0.01, 0.03, 0.05, 0.07, 0.09, 0.11 and 0.13 
s. Heteronuclear 15N{1H}-NOEs were measured with a saturation delay of 5 s. 
Heteronuclear NOE values were generated by comparing the peak intensity ratio of 
[1H, 15N]-HSQC NMR spectra with and without 1H saturation (Farrow, Muhandiram et 
al. 1994). Sparky 3.110 software (Goddard and Kneller, 2004) was used to determined 
T1 and T2 values by exponential fitting of the decay intensities.  
Spectra measured on Varian and Bruker spectrometers were recorded and processed 
with VNMRJ and TopSpin, respectively. Specific resonance assignment was done 
?? ?
using Sparky 3.110 software (Goddard and Kneller, 2004) and CcpNmr analysis 
(Vranken, Boucher et al. 2005). 
 
7.7.2 Determination of NMR solution structure  
 
For structure determination of HpTonB-CTD(179 – 285), 15N-edited NOESY-HSQC 
and 13C-edited NOESY-HSQC spectra with 70 ms and 90 ms mixing time, 
respectively, were recorded. For structure determination of HpTonB-CTD(194 – 285) 
15N- and 13C-edited NOESY-HSQC with 90 ms mixing time were recorded. For 
structure determination of BsMreC (104 – 279), 15N- and 13C-edited NOESY-HSQC 
spectra with 100 ms mixing time were recorded.  
Structure calculations were performed using Cyana 3.0 structure calculation software 
(Guntert 2009). As input for automated structure calculations, chemical shift 
assignments, unassigned NOE peak lists and protein backbone angle data based on 
chemical shifts and provided by TALOS+ software (Shen, Delaglio et al. 2009) were 
used for automated NOE assignments incorporated in Cyana 3.0 (Herrmann, Guntert et 
al. 2002). Typically, 200 structures in each cycle were calculated and the 20 structures 
with the lowest Cyana target function were energy refined using AMBER 14 (Case, 
Cheatham et al. 2005; Bertini, Case et al. 2011). For structure quality evaluation and 
validation, the protein structure validation software suite PSVS 1.5 (Bhattacharya, 
Tejero et al. 2007) and WHAT IF (Vriend 1990; Kabsch and Sander 1983) were used.  
 
7.7.3 NMR titration studies of BsMreC with PBP2a 
?
NMR titration studies to investigate the interaction of BsMreC and BsPBP2a with 
different constructs of both proteins were conducted. [1H, 15N]-HSQC spectra of a 
protein mixture of different molar ratios in 20 mM NaPi, pH 6.5, were measured on a 
Varian INOVA 800 MHz spectrometer equipped with a cryogenically cooled probe 
head at 303 K. Table 1 shows a summary of the different constructs and their 
concentrations and molar ratios that have been used for the titration studies. A 
reference [1H, 15N]-HSQC spectrum of all 15N-labelled BsMreC constructs was 
measured before starting with the titration. The NMR sample volume of the titration 
samples was between 250 and 450 μl, depending on the ratio of the two proteins. The 
?? ??
sample was transferred into a 5 mm Varian NMR tube. The titration samples contained 
8% D2O.  
 
Table 1. Protein conditions for NMR titration studies of BsMreC and BsPBP2a 
 15N-BsMreC 
(res 104-279) 
BsPBP2a 
(res 60-689) 
BsMreC :  BsPBP2a 
Titration 1 0.1 mM 0.05 mM 1 : 0.5 
0.1 mM 0.1 mM 1 : 1 
0.1 mM 0.2 mM 1 : 2 
Titration 2 15N-BsMreC 
(res 104-279) 
BsPBP2a 
(res 60-689) 
BsMreC :  BsPBP2a 
0.05 mM 0.26 mM ~ 1 : 5 
0.025 mM 0.26 mM ~ 1 : 10 
Titration 3 15N-BsMreC 
(res 104-279) 
BsPBP2a 
(res 43-689) 
BsMreC :  BsPBP2a 
0.2 mM 0.1 mM 1 : 0.5 
0.1 mM 0.1 mM 1 : 1 
0.066 mM 0.2 mM 1: 3 
0.04 mM 0. 2 mM 1 : 5 
Titration 4 15N-BsMreC 
(res 25-279) 
BsPBP2a 
(res 43-689) 
BsMreC :  BsPBP2a 
0.06 mM 0.03 mM 1 : 0.5 
0.06 mM 0.06 mM 1 : 1 
0.05 mM 0.1 mM 1 : 2 
0.04 mM 0.15 mM ~ 1 : 4 
Titration 5 15N-BsMreC 
(res 104-290) 
BsPBP2a 
(res 43-689) 
BsMreC :  BsPBP2a 
0.05 mM 0.2 mM 1 : 4 
0.1 mM 0.2 mM 1 : 2 
0.1 mM 0.1 mM 1 : 1 
 
7.8 Preparation of Figures 
 
Spectrum illustrations presented in this thesis were done using Sparky 3.110 (Goddard 
Kneller, 2004) and CcpNmr 2.4.1 (Vranken, Boucher et al. 2005). MOLMOL (Koradi, 
Billeter et al. 1996) and PyMOL (DeLano, 2002) programs have been used to create 
the figures representing protein structures. Secondary structure elements in the figures 
were calculated with a DSSP algorithm using WHAT IF (Kabsch and Sander 1983; 
Touw, Baakman et al. 2015). 
?? ?
8 RESULTS AND DISCUSSION 
 
8.1 TonB solution structures 
 
NMR spectroscopy was used to determine the solution structure of the C-terminal 
domain of HpTonB (TonB-CTD). H. pylori are Gram-negative pathogenic bacteria 
living in the stomach of humans and it has been estimated that about 50% of the 
world’s population are infected with H. pylori (Pellicano, Ribaldone et al. 2016). H. 
pylori causes gastritis and peptic ulcer (PU) and people infected with H. pylori have an 
increased lifetime risk in developing gastric cancer (Chang and Parsonnet 2010). 
Furthermore, H. pylori has been shown to be associated with colorectal cancer (Wu, 
Yang et al. 2013).  
TonB protein is part of the TonB-system, which is responsible for the TonB-dependent 
uptake of scarce nutrients and involves an outer membrane receptor (OMR) (Krewulak 
and Vogel 2008). Recent studies showing structural insights of the TonB complex, 
revealed that the TonB-system is composed of an ExbB pentamer, ExbD dimer and at 
least one TonB protein (Celia, Noinaj et al. 2016). Two mechanistic models were 
suggested for production of energy from the proton motive force; these involve either a 
rotational motion or an electrostatic piston motion of the oligomer (Celia, Noinaj et al. 
2016). However, the exact role of TonB, in particular regarding the putative 
conformational changes needed for energy transduction remains elusive. Structural 
studies of TonB could help provide new insights about the energy transduction 
mechanism. The TonB protein is composed of three domains, a TM domain, a proline-
rich flexible domain and a well-structured C-terminal domain (CTD), which interacts 
with the TonB-box of the OMR (Evans, Levine et al. 1986). This C-terminal domain 
was used for the structural studies in this thesis. At the time studies III and IV were 
performed, X-ray crystal structures as well as an NMR solution structure of TonB-
CTD from E. coli were available (Kodding, Killig et al. 2005; Chang, Mooser et al. 
2001; Sean Peacock, Weljie et al. 2005). The residue range of HpTonB-CTD used in 
this study is based on sequence homology of TonB from other organisms and on 
published structures. NMR solution structure was determined from two different 
constructs consisting of residues 194 – 285 (short construct) and 179 – 285 (long 
construct), respectively.  
?? ??
8.1.1 Solution structure of the short construct of HpTonB-CTD 
 
To determine whether the construct consisting of residues Ser194 – Asp285 was 
suitable for structural NMR studies, it was expressed as a stable isotopically labelled 
protein (II and III). The [1H, 15N]-HSQC spectrum (III), which showed well dispersed 
proton signals ranging from 6.4 to 9.5 ppm, indicated that the protein was globular and 
thus suitable for structural studies (III). However, the [1H, 15N]-HSQC spectrum 
showed some additional small signals that could not be assigned and might arise from 
a different conformation. In total 97.3% of the backbone atoms, which include C´, Cα, 
Cβ, N and H, could be assigned, as well as 93.5% and 85.4% of the expected aliphatic 
and aromatic side chain atoms, respectively. From the protein backbone, the amide 
signals of Ser194, Asn195 and Lys213 were not observed in the [1H, 15N]-HSQC 
spectrum, and as a consequence, the side chain resonances of Lys213 were not 
observed in the triple resonance spectra. The missing resonance assignment for Lys213 
is likely to be caused by a conformational exchange that leads to line broadening of the 
NMR signal. The calculation of the solution structure was done using distance 
restraints derived from 13C- and 15N-edited HSQC-NOESY spectra. Quality statistics 
of the structure are shown in Table 2 (III). Important criteria to assess structural 
quality are the type and numbers of distance restraints used. Long-range NOEs are 
structurally more important than medium- and short-range NOEs. Long-range NOEs 
are observed between two protons on residues that are separated by five or more 
residues in the sequence, whereas short-range NOEs and medium-range NOEs are 
observed between protons of the same residue and between protons on residues 
separated by 1 to 4 residues in the sequence, respectively. Furthermore, the mere 
number of NOEs per residue also defines the structural quality. An NMR structure 
with at least 20 restraints per residue is equivalent to a crystal structure with a 
resolution of about 2 – 2.5 Å (Kwan, Mobli et al. 2011). However, this comparison 
does not consider the different types of distance restraints and therefore has to be 
interpreted carefully.  
The relatively low number of NOEs per residue (12.9) for HpTonB (194 – 285) also 
explains the higher rmsd to mean coordinate (Table 2). The backbone RMSD for the 
residues 196 – 282 is 0.77 Å ± 0.11 and the most disordered regions are found, besides 
the N- and C-termini, in the loop between α-helix 1 and 2 where amide and side chain 
signals were unassigned for residue Lys213 and consequently no NOE could be 
?? ?
assigned for arranging the backbone conformer. The rmsd from ideal geometry 
describe how well the structure fits to expectations with respect to ideal values or value 
distribution obtained from a large database of high-quality resolution crystal structures. 
Included are bond length and bond angle distribution. Criteria for a high quality crystal 
structure are < 0.02 Å for rmsd bond lengths and < 2 ° for rmsd bond angles (Jaskolski, 
Gilski et al. 2007).  
The evaluation of the residual distance and dihedral angle violations, meaning an 
inconsistency between a restraint and the structure, is crucial for the quality of the 
structure. The ideal is to have no violations of any restraint. However, maximum NOE 
violations of < 0.5 Å and dihedral angle violations of < 5 ° are considered to be 
acceptable upper limits. All structures presented here fulfil these criteria (Tables 2, 3 
and 4). The Ramachandran scores show the consistency between the backbone phi and 
psi angles of the model structure compared to those observed in the reference database. 
For a high quality structure, > 95% is expected to be in the most favoured region. The 
regions are defined by MolProbity (Chen, Arendall et al. 2010). In the structure of 
HpTonB (194 – 285), one outlier (Met214) is located in a more disordered region in 
the loop between helices αI and αII. This residue has missing assignments in the side 
chain and only few NOEs were observed.  
The global quality scores derived from PSVS are based on comparison with a large 
database of high-resolution crystal structures (Bhattacharya, Tejero et al. 2007). The 
different global quality scores are explained here briefly: Verify3D reports on how 
compatible the environment of each residue in the structure is in comparison with the 
statistical preferences of environments of amino acids (Lüthy, Bowie et al. 1992). 
Prosa assesses a pseudoenergy based on distances between alpha carbon atom pairs 
and the solvent exposure of protein residues for the model structure (Sippl 1993). 
Procheck describes the probability of the dihedral angles of a residue in the model 
structure to be in a usual range; this is reported as the G-factor (Laskowski, MacArthur 
et al. 1993). MolProbity reports on overpacking by giving a clashscore, which is the 
number of close contacts, below 0.4 Å, per 1000 atoms (Chen, Arendall et al. 2010).  
Z-scores for the Prochek G factor and the MolProbity clashscore should be > -3 for 
data deposition on the PDB server (Bhattacharya, Tejero et al. 2007).  
Atomic coordinates of HpTonB (194 – 285) and backbone and side chain assignment 
are available in the PDB database under the accession code 5LW8 and 34043, 
respectively.  
?? ??
Table 2: Structural statistics of the 20 energy-minimized conformers of  
HpTonB (194 – 285) 
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The ensemble of the 20 NMR derived conformers and the solution structure showing 
the secondary structure elements are shown in Figure 7. The structure contains three 
α-helixes and a β-sheet composed of three antiparallel β-strands, with a β3-strand 
located at the C-terminus. In comparison to the previously published solution (Sean 
Peacock, Weljie et al. 2005) and crystal structures (Chang, Mooser et al. 2001) of 
?? ?
TonB-CTD from E. coli, the solution structure of HpTonB-CTD revealed an additional 
α-helix (αI) at the N-terminus, ranging from Glu196 to Lys208. In order to investigate 
the possible continuation of this additional α-helix of the well-structured CTD, we 
decided to make a longer construct of HpTonB-CTD.  
 
 
 
 
 
 
 
 
 
 
 
Figure 7: The solution structure of HpTonB (194-285) (PDB code: 5LW8) a) Assembly of the 
20 refined NMR structures of HpTonB (194-285). Residues 196-282 are superimposed. b) 
Solution structure of HpTonB (194-285) of the lowest energy structure. The secondary 
structure elements and N- and C-termini are marked. 
 
8.1.2 Solution structure of the long construct of HpTonB-CTD 
?
The initial NMR analysis of the [1H, 15N]-HSQC spectrum of the longer construct of 
HpTonB-CTD consisting of residues Ser179 – Asp285 indicated a well-folded domain. 
Almost all backbone amide signals were visible and well dispersed ranging from 6.4 to 
9.5 ppm (IV). No additional signals were observed in the [1H, 15N]-HSQC spectrum of 
the longer construct compared to the [1H, 15N]-HSQC spectrum of the shorter 
construct, which indicates a stable protein with one conformation. For determination of 
the solution structure, chemical shift assignment could be done for 98.8% of backbone 
atoms, which include C´, Cα, Cβ, N and H. 96.5% and 81.3% of expected aliphatic and 
aromatic side chains, respectively, could be assigned. The amide signal of Lys213 was 
not visible in the [1H, 15N]-HSQC spectrum, which is comparable to the short 
construct, probably due to a conformational exchange that leads to line broadening of 
?? ??
the NMR signal. The structure of HpTonB-CTD (179 - 285) was solved using distance 
restraints derived from 13C- and 15N-edited HSQC-NOESY spectra. Quality statistics 
of the 20 NMR derived conformers represent successful structure determination, as 
shown in Table 3 (V, Table 1). 
 
Table 3: Structural statistics of the 20 energy-minimized conformers of  
HpTonB (179 – 285) 
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?? ?
The backbone RMSD for the well-determined structure is 0.40 Å ± 0.05 and for the 
heavy atoms 0.86 Å ± 0.06 for the region Thr183 - Lys283 determined by MOLMOL 
(Koradi, Billeter et al. 1996). The structure of the long construct of HpTonB-CTD (179 
– 285) and the short HpTonB-CTD (194 – 285) construct are superimposed in Figure 
8.  
 
 
 
 
 
 
 
 
 
 
Figure 8: Superimposed solution structure lowest energy conformers of HpTonB (194–285) 
(grey) and HpTonB (179-285) (orange). 
 
Significant differences regarding the orientation of the N-terminal helix (αI) and at the 
C-terminus could be observed. The superimposition of the lowest energy structures of 
HpTonB-CTD (194 – 285) and HpTonB-CTD (179 – 285) gives a relatively high 
RMSD of 1.4 Å for 78 residues (without N- and C-terminal residues). The long 
construct continues well structured at the N-terminus, where it also contains a short 
additional α-helix (α0). Figure 9 shows the ensemble of 20 NMR refined structures, 
the lowest energy model showing the secondary structure elements and the model 
showing the electrostatic surface potential. In general, the low rmsd to mean coordinate 
(Table 3) suggests that the longer construct is better determined than the shorter 
construct, and the results suggest that the longer construct might be less dynamic and 
more stable. However, 15N-relaxation studies of both constructs will be conducted for 
more detailed analysis of protein dynamics. The number of structurally important long-
range NOEs, shown in Table 3 is significantly higher for the longer construct than for 
the shorter construct, which is partly explained by the higher assignment percentage 
compared to the shorter construct. 
???
Figure 9: The solution structure of HpTonB (179-285). a) Superimposed 20 refined NMR 
structures. Residues 183-283 are superimposed. b) Secondary structure elements of the 
lowest energy structure. c) Electrostatic surface potential. 
A superimposition of HpTonB-CTD (179 – 285) with the previously published NMR 
structure of E. coli TonB-CTD (151 – 239) (PDB: 1XX3) (Sean Peacock, Weljie et al. 
2005) is shown in Figure 10. The rmsd of the aligned structures over 81 residues is 2.7 
Å. The structures share clear similarities but also differences, in particular regarding 
the N- and C-termini. The β-sheet composed of the three long β-strands and the short 
and long central α-helices align well. The biggest differences are the missing long α-
helix at the N-terminus of the E. coli structure and the additional β -strand at the C-
terminus of the E. coli structure, which is not found in H. pylori TonB.  
Figure 10: Superimposed solution structure of HpTonB (179–285) (orange) and E. coli TonB 
(151-239) (blue). 
?? ?
8.2 Segmental isotopic labelling of TonB 
 
TonB transduces the energy required for the transport of scarce nutrients through the 
outer membrane to the OMR. However, it remains elusive how exactly the energy 
coming from the proton motive force is converted to mechanical energy, which is 
stored in TonB, and how it is released when used for the transport. It has been 
suggested that TonB undergoes a conformational change (Postle and Kadner 2003). 
The flexible proline-rich domain is responsible for extending the protein through the 
periplasmic space (Evans, Levine et al. 1986) and might interact with the well 
structured CTD during the energy transduction. Segmental isotopic labelling was 
performed to enable structural investigations of the CTD in the presence of the flexible 
proline-rich domain and therefore, in almost the full-length context. Only the TM 
domain was omitted for this study. The scarless segmentally isotope labelled construct 
was successfully produced by salt induced protein trans splicing using the strictly 
halophilic HutMCM2 intein, which consists of residues Arg36 - Asp285 and has an 
15N-labelled CTD (155 – 285) (III). The [1H, 15N]-HSQC spectrum of the segmentally 
isotope labelled HpTonB [36-285(15N(155-285))] shows signals that are well dispersed 
indicating a folded domain, whereas the [1H, 15N]-HSQC of the uniformly 15N-labelled 
HpTonB (36-285) shows severely overlapping signals between 8.0 and 8.5 ppm 
(Figure 5). An overlay of the segmentally isotope labelled HpTonB [36-285(15N(155-
285))] and the uniformly 15N-labelled HpTonB (36-285) is shown in Figure 11.  
 
 
 
 
 
 
 
 
 
 
 
 
 
?? ??
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Overlay of [1H, 15N]-HSQC spectra of segmentally labelled HpTonB [36-
285(15N(155-285))] (dark blue) and uniformly labelled HpTonB (36-285) (grey) protein sample 
in 20 mM NaPi, pH 6.0. The flexible pro-rich region between 8.0 and 8.5 ppm interferes with 
the well dispersed signals of the segmentally labelled protein. The spectra were recorded with 
a Bruker AVANCE III 850 MHz spectrometer at 298 K.  
 
Interestingly, chemical shift perturbation (CSP) studies of the segmentally isotope 
labelled HpTonB [36-285(15N(155-285))] and HpTonB-CTD (194 – 285) using 
chemical shift differences of backbone amides from [1H, 15N]-HSQC spectra of both 
proteins revealed that the presence of the pro-rich domain might induce large chemical 
shift perturbations not only in the N-terminal region, but remarkably also in the β-
sheet, in particular in the C-terminal β3-strand, which is supposed to be involved in 
binding to the TonB-box of the OMR (Sean Peacock, Weljie et al. 2005) (III). These 
results indicate that the flexible pro-rich domain probably structurally influences the 
well-structured CTD, and furthermore underline the importance of structural 
investigations of protein domains in the full-length context (III).  
 
?? ?
8.2.1 Salt-inducible protein trans splicing for segmental isotopic labelling 
 
For salt inducible protein trans splicing (PTS), the strictly halophilic HutMCM2 intein 
was used. The novel artificially HutMCM2 split intein has been shown to splice 
efficiently with fast splicing kinetics (III, Figure 2, Suppl. Figure 1 and 2) compared 
to the well-studied split intein DnaE from Nostoc punctiforme and additionally with 
few side products compared to the other strictly halophilic intein, CDC21 intein from 
Halobacterium salinarum (III, (Iwai, Zuger et al. 2006; Ellila, Jurvansuu et al. 2011). 
The highly soluble HutMCM2 split intein was used for protein ligation of N- and C- 
terminal precursors of HpTonB (III, Figure 6). The individually expressed and 
purified precursors, the unlabelled N-terminal precursor and the 15N-labelled C-
terminal precursor were successfully ligated by salt induced PTS using the HutMCM2 
split intein (III, Figure 6). Remarkably, the HutMCM2 intein uses Ser at the +1 
position of the junction sequence in the C-extein instead of Cys (III), which is, for 
example, used by the NpuDnaE intein (Iwai, Zuger et al. 2006). Since Ser is more 
abundant than Cys in native proteins, the use of the HutMCM2 intein is advantageous 
for segmental isotopic labelling, since it facilitates protein ligation that results in native 
sequences without incorporated extra residues that could interfere with structural 
investigations by NMR (III). Furthermore, the -1 residue position of the N-extein 
usually influences the splicing efficiency of a certain intein as has been shown 
previously (Oeemig, Zhou et al. 2012). The splicing efficiency was about 30% after a 
one day dialysis when the native Lys154 at the -1 position was used, whereas a 
splicing efficiency of about 80% after a two dialysis could be observed when Arg was 
used at the -1 position of the N-extein (III). These results strengthen the previous 
observations that the residues at the -1 and the -2 position of the junction sequences 
influence the splicing efficiency (Oeemig, Zhou et al. 2012). However, since 
HutMCM2 is highly efficient and produces fewer side products than other halophilic 
inteins like HsaCDC21, a sufficient amount of pure ligated product for structural 
investigation by NMR could be obtained by a second purification step after the salt 
inducible trans splicing reaction (III, Figure 6).  
 
 
 
?? ??
8.3 Soluble protein expression for NMR 
?
As described previously, for structural investigations of proteins by NMR, usually a 
high yield of purified recombinant protein is advantageous and therefore soluble 
expression of proteins in competent E. coli cells should be optimized. Smt3 has been 
used as a fusion tag and solubility enhancer for expression and purification of various 
proteins. However, not all proteins are expressed in a soluble form, even when Smt3 is 
used, as has been shown for example with TonB-CTD of different lengths from E. coli 
and Pseudomonas aeruginosa (II). Therefore, different solubility enhancers like MBP, 
Trx, GST and trigger factor (TF) in combination with the Smt3 fusion tag for 
convenient protein purification were used to test soluble expression of proteins that 
tend to be expressed in an insoluble form. In the case of HpTonB-CTD (194 – 285), 
soluble protein expression could be achieved when using Smt3-HpTonB or Smt3-
MBP-HpTonB fusion constructs (II). Although the expressed protein was more soluble 
when MBP fusion was used, the Smt3-HpTonB fusion was used for NMR studies (II). 
The final yield of TonB-CTD (194 – 285) was about 50% higher when only Smt3 
fusion was used because of the high molecular weight of MBP (42 kDa) (II). All 
fusion constructs and the Ulp1403-621 protease contained a His6-tag and the proteins 
were successfully purified by two subsequent immobilized metal ion affinity 
chromatography (IMAC) steps before and after the Ulp1403-621 digestion (II, Figure 7). 
The [1H, 15N]-HSQC spectrum of HpTonB-CTD (194 – 285) shows the well-separated 
signals of a globular protein (II, Figure 7). Furthermore, the comparison of the amide 
signals in the [1H, 15N]-HSQC spectrum of EcTonB-CTD (151 – 239) expressed as a 
Smt3-MBP-EcTonB-CTD (151 – 239) fusion protein with the previously assigned 
chemical shifts of the EcTonB-CTD (BMRB ID: 6375) (Sean Peacock, Weljie et al. 
2005) reveals that almost all signals are superimposed (II, Figure 5). This result 
indicates that the solution structure of the EcTonB-CTD (151 – 239) expressed with 
different solubility enhancing fusion tags is identical to the previously published 
solution structure (II, (Sean Peacock, Weljie et al. 2005)). 
  
8.4 MreC solution structure and interaction studies 
?
The cell shape determining protein MreC has been shown to interact with proteins 
involved in cell wall synthesis, such as PBPs in E. coli, B. subtilis, H.pylori, and C. 
?? ?
crescentus (Figge, Divakaruni et al. 2004; Divakaruni, Loo et al. 2005; van den Ent, 
Leaver et al. 2006; El Ghachi, Mattei et al. 2011) The extracytoplasmic domain of 
MreC is supposed to be involved in the interaction of MreC with PBPs (El Ghachi, 
Mattei et al. 2011). Our first aim was to determine the solution structure of the 19 kDa 
extracytoplasmic domain of BsMreC consisting of residues Gly104 – Asp279 (V). The 
structural information could then be used to study the interaction of MreC with PBPs 
and the structural basis of this interaction.  
?
8.4.1 Solution structure of the extracytoplasmic domain of BsMreC 
 
The [1H, 15N]-HSQC spectrum of BsMreC (104 – 279) shows well-resolved signals of 
a globular protein (I, Figure 1). For the structural calculations, the specific resonance 
assignment of BsMreC (104 – 279) was obtained using a standard set of triple 
resonance spectra where 96.7% of C´, Cα, Cβ, N and H backbone atoms and 93.2% 
and 100% of aliphatic and aromatic side chain atoms were assigned, respectively (V). 
The low assignment percentage for the aliphatic side chains can partly be explained by 
the severely overlapping signals of the 23 lysine side chains. Furthermore, not all 
backbone signals could be observed in the [1H, 15N]-HSQC spectrum, probably due to 
conformational exchange that leads to line broadening of the NMR signal. Missing 
assignments for backbone amides are found in the more disordered regions in the loop 
between the β4- β5-strands (Gly162 and Asn165) and in the loop between the β6- and 
β7-strands (Lys189, Lys190, Ser192) and further in the loop between the β10- and 
β11-strands (Ser252). Additionally, the backbone amide of Arg178 located in the 
linker region between the two domains remained unassigned.  
The [1H, 15N]-HSQC spectrum of BsMreC (104 – 279) showed some additional signals 
that could not be assigned and might arise from a different conformation (I). The NMR 
structure determination was based on automated NOE assignments from 15N- and 13C 
edited HSQC-NOESY spectra and dihedral angle backbone predictions. Structural 
statistics are shown in Table 4 (V).  
 
 
 
 
 
Table 4: Structural statistics of BsMreC (104-279) solution structure 
 
The structure, which consists of two β-barel like domains, each composed of 6 
antiparalel β-strands, where the last strand, the β12-strand, is part of the first domain 
and brings the N- and C-termini together, is shown in Figure 12. 
 
 
 
?? ?
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: The solution structure of BsMreC (104-279). a) Superimposed 20 refined NMR 
structures. Residues 111-276 are superimposed. b) Secondary structure elements of the mean 
structure of BsMreC (104-279). 
 
The high RMSD of 0.95 Å for backbone atoms can partly be explained by the missing 
NOEs in the interface of the two domains. These missing NOEs partly arise from 
missing chemical shift assignments of atoms found in the domain interface (Gly233 
and part of the side chain atoms of Asp202). The individual domains however, show 
well-defined long-range NOE networks and the RMSD for backbone atoms is 0.51 Å 
and 0.66 Å for the first and the second domain, respectively (V, Figure 3). The 
disordered loop between the β9- and β10-strand of domain 2 has been excluded for the 
RMSD calculations of the second domain. These results might suggest that the two 
domains are not rigid to each other. However 15N-relaxation studies revealed that there 
is no significant difference in the dynamic behaviour of the two domains (V, Figure 
6).  
 
 
 
?? ??
8.4.2 NMR titration studies of MreC with PBP2a 
 
For the NMR titration studies of BsMreC with BsPBP2a, different constructs of both 
proteins were investigated based on literature describing the putative interaction and 
active sites of the proteins (see experimental procedure). The constructs contained the 
previously described minimal region, ranging from Lys135-Tyr260, of BsMreC that is 
required for interaction with PBPs (El Ghachi, Mattei et al. 2011). The structure of a 
high-molecular weight PBP, PBP2a from S. aureus, was solved in 2002 (Lim and 
Strynadka 2002) and revealed that the transpeptidase domain is located away from the 
membrane and includes the C-terminal part of the protein. The catalytic mechanism 
has been described and Ser403 has been identified as a key residue for interaction with 
β-lactam antibiotics (Lim and Strynadka 2002). Results derived from small-angle X-
ray scattering (SAXS) have suggested that interaction between MreC and PBP2a is 
more likely to occur at the N-terminus of PBP2a, which is located closer to the 
membrane (El Ghachi, Mattei et al. 2011). Based on these findings we designed 
constructs of BsMreC and BsPBP2a for the NMR interaction studies. [1H, 15N]-HSQC 
spectra of truncated 15N-labelled BsMreC with different concentrations of truncated 
unlabelled BsPBP2a were measured. However, spectral analysis for detailed 
characterization of the interaction between these two proteins turned out to be more 
complex. Overall, the results were comparable for all constructs, no significant 
chemical shift changes could be observed for any residue in the [1H, 15N]-HSQC 
spectra. Shifting of resonances indicates binding. However, changes in intensity 
occurred and for increasing concentrations of BsPBP2a compared to BsMreC, the 
signals started to disappear due to line broadening. With a BsMreC-BsPBP2a ratio of 1 
: 2 and higher more than 50% of the signals disappeared completely. Furthermore, the 
spectra show signals mainly between 8.0 and 8.5 ppm, which indicate that BsMreC 
might not be properly folded anymore. With these results from the interaction studies it 
was not possible to determine an interaction site in BsMreC. Figure 13 shows an 
overlay of [1H, 15N]-HSQC spectra with BsMreC-BsPBP2a ratios of 1 : 1 and 1 : 2, 
respectively. The large molecular size of the BsPBP2a constructs (around 70 kDa) 
might contribute to the large changes in intensities. However, to conclude, the NMR 
interaction studies that were conducted did not reveal a direct interaction between the 
two proteins and any characterization of the interaction domain could not be done.  
 
?? ?
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: Overlay of [1H, 15N]-HSQC spectra of NMR titration studies of BsMreC (104-279) 
and BsPBP2a (60-689) measured in 20 mM NaPi, pH 6.5 on a Varian INOVA 800 MHz at 303 
K. a) Titration with molar ratio 1 : 1; BsMreC 0.1 mM : BsPBP2a 0.1 mM (black) overlayed on 
reference [1H, 15N]-HSQC spectra of 0.1 mM BsMreC (red). b) Titration with molar ratio 1 : 2; 
BsMreC 0.1 mM : BsPBP2a 0.2 mM (cyan) overlayed on reference [1H, 15N]-HSQC spectra of 
?? ??
0.1 mM BsMreC (red). The chemical shift assignments of the amide backbone are shown in b) 
using the one-letter amino acid code and the Asn and Gln Side chains are marked with “sc”. 
 
In order to investigate the integrity of BsPBP2a, BOCILLIN FL, a fluorescent 
penicillin, was used as a labelling reagent to show the activity of BsPBP2a (Zhao, 
Meier et al. 1999). Figure 14 shows the gel of the BOCILLIN FL stain. The result 
confirms that PBP2a binds BOCILLIN FL and is therefore supposed to be active and 
in its native state.  
 
 
 
 
 
 
 
 
 
Figure 14: Bocillin FL stain of BsPBP2a (43 – 689). a) Different concentrations of BsPBP2 
were incubated with Bocillin FL (10 μg): Lane: 1: 100 μg, Lane 2: 10 μg, Lane 3: 1 μg. 
Fluorescently labelled BsPBP2a (43 – 689), indicated with an arrow, was visualized with 
Typhoon 9400 (488 nm) (Amersham Biosciences). b) Coomassie Blue staining indicates the 
correct size of BsPBP2a (43 – 689). 
 
8.4.3 Bacterial two-hybrid system 
 
Since direct interaction between BsMreC and BsPBP2a could not be shown, we 
performed a bacterial two-hybrid system analysis to investigate the putative interaction 
of these proteins (Karimova, Pidoux et al. 1998). Bacterial two-hybrid analysis has 
been previously used to show the interaction of MreC and PBP2a in B. subtilis (van 
den Ent, Leaver et al. 2006) and C. crescentus (White, Kitich et al. 2010). One 
advantage of the bacterial two-hybrid system used in this study is that it can be used 
with membrane proteins (Battesti and Bouveret 2012). Therefore, interaction of full-
length proteins could be investigated. Different constructs (see experimental 
?? ?
procedure) of BsMreC and BsPBP2a were used for this interaction study. The results 
were comparable to the previously published results (van den Ent, Leaver et al. 2006; 
White, Kitich et al. 2010) and revealed a clear interaction between BsPBP2a and full-
length BsMreC (residues 1 – 290) and between BsPBP2a and the C-terminal truncated 
BsMreC (residues 1 – 279). Furthermore, an interaction could also be observed 
between BsPBP2a and the extracytoplasmic domain of BsMreC (1-23/104-279) 
(consisting of the TM and C-terminal domains without the coiled coil domain). 
However, the results suggest that this interaction is significantly weaker than the 
interaction with full-length BsMreC, which indicates that dimerization of BsMreC that 
is supposed to occur via the coiled coil domain (van den Ent, Leaver et al. 2006) might 
be important for the interaction with BsPBP2a. Furthermore, these results suggest that 
BsMreC and BsPBP2a might not interact directly but that the interaction of these 
proteins might depend on other proteins. Figure 15 shows bacterial two-hybrid data of 
the interaction observed between the full-length BsMreC and BsPBP2a and between 
the BsMreC missing the coiled coil domain and the full-length BsPBP2a. A negative 
control is also shown in Figure 15. More detailed, quantitative analysis, however, 
remains to be done and requires a more extensive setup of the bacterial-two hybrid 
system.  
 
 
 
 
 
 
 
 
 
Figure 15: Interaction of BsMreC with BsPBP2a tested with Bacterial two-hybrid system. a) 
Blue colonies show interaction between full-length BsMreC and BsPBP2a. b) Weaker 
interaction was observed between BsMreC (1-23/104-279) missing the coiled-coil domain and 
full-length BsPBP2a. c) Control plate of pUT18 and pKT25 vector without insert showing no 
interaction. 
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9 CONCLUSION AND FUTURE PERSPECTIVES 
 
Antibiotic development and discovery has slowed down and most of the newly 
introduced antibiotics during the last 30 years are chemical variations of already 
existing drugs (Silver 2011). The reasons for this are not only scientific and correspond 
to difficulties in drug discovery, but are also commercial: The development of novel 
antibiotics is time consuming and antibiotics are used only for a short period of time to 
treat acute microbial infections. Therefore they are not considered as economically 
beneficial by pharmaceutical companies as, for example, drugs for treatment of chronic 
diseases, which are usually used for a lifetime (Power 2006). However, antibiotic 
resistance is a global threat and the development of novel antimicrobial drugs is 
required for combating the spread of antibiotic resistant strains.  
In this study, two potential targets for new-generation antibiotics, TonB and MreC, 
were structurally investigated by NMR.  
The determination of HpTonB-CTD solution structures of different lengths (III and 
IV) is the first step for further functional investigations including the detailed 
characterization of the interaction of HpTonB-CTD with the TonB-box of the OMR. 
NMR interaction studies of HpTonB-CTD with the TonB-box peptide of the OMR 
from H. pylori will be conducted in the next phase of this project. An ultimate goal of 
this research would be to design inhibitors to block protein-protein interactions using 
computational tools such as molecular docking (Stark and Powers 2012). Furthermore, 
it may be possible to screen libraries and identify high affinity ligands by NMR, e.g. by 
structure-activity relationships (SAR) (Shuker, Hajduk et al. 1996).  
After determination of the solution structure of the extracytoplasmic domain of 
BsMreC (I and V), extensive NMR titration studies to structurally investigate the 
putative interaction of PBP2a and MreC, using different constructs of both proteins 
have been done. However, despite the previously proposed MreC-PBP2a interaction 
(van den Ent, Leaver et al. 2006; El Ghachi, Mattei et al. 2011), direct interaction 
could not be observed by NMR (this study). A bacterial two-hybrid system (Karimova, 
Pidoux et al. 1998), however revealed an interaction, in particular between full-length 
BsMreC and BsPBP2a (this study). Since bacterial two-hybrid analysis provides only 
an indirect method for measuring the interaction of two proteins (Battesti and Bouveret 
2012), it has to be considered that the interaction might be dependent on additional 
protein(s) or other cofactors. Additional interaction studies, using different methods, 
?? ?
like isothermal titration calorimetry (ITC) or Biacore (Leonard, Hearty et al. 2011) will 
be used to further investigate the putative interaction of MreC and PBP2a. For possible 
detailed characterization at the atomic level by NMR, more detailed information about 
the putative interaction site would be advantageous for planning of the constructs. 
 
The second part of this study has been based on biotechnology and the use of TonB 
protein as a bioengineering tool. TonB was used for these projects for the following 
reasons: (i) Recombinant expression of TonB-CTD constructs consisting of different 
lengths and from different bacterial organisms revealed that some of the constructs 
tend to be expressed in an insoluble form. However, for structural investigation by 
NMR, a high yield of soluble, correctly folded protein is crucial (II). Therefore, TonB 
was successfully used to test improved soluble protein expression and purification with 
tandem-SUMO fusion vectors containing the solubility enhancers Smt3, which 
facilitates protein purification using the Ulp1 protease, and MBP, Trx or GST (II).  
(ii) Since TonB protein is composed of three domains, a TM domain, a disordered pro-
rich domain and a well-structured CTD, it is a good target protein to demonstrate the 
advantages of segmental isotopic labelling (III). Segmental isotope labelling allows 
the structural investigation by NMR of individual protein domains in the presence of 
flexible domains or domains with residue repeats. It enables structural investigation of 
protein domains in a full-length context and, for example, provides structural 
information about the influences of the disordered region on the structured part of the 
protein. NMR structural studies of segmental isotope labelled TonB protein revealed 
that the flexible pro-rich domain might structurally influence the CTD (III). These 
results might lead to a better understanding of the process of energy transduction via 
the TonB-system to the OMR during the uptake of scarce nutrients in Gram-negative 
bacteria. The novel artificially split HutMCM2 intein from extreme halophilic archaea 
was used for successful protein ligation of the unlabelled and labelled domain by salt 
induced protein trans splicing (III). The next step in this project is the determination of 
the solution structure of the segmentally isotope labelled construct of HpTonB 
consisting of residues Ser155 – Asp285.  
 
In summary this thesis provides structural information of specific bacterial proteins 
involved in essential cellular processes, which might serve as a basis for additional 
?? ??
functional studies and help in better understanding the molecular aspects of these 
cellular processes.  
Furthermore, this thesis demonstrates advantages for structural investigation of 
proteins by NMR with specific examples of protein engineering: Firstly, by evaluating 
fusion vectors for more soluble protein expression and secondly by demonstrating a 
simple method for traceless segmental isotopic labelling by salt induced PTS.   
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